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Abstract 
Concurrent with a rise in opioid abuse during pregnancy is an increase in the number of babies 
born with Neonatal Abstinence Syndrome (NAS).  Despite this crisis, no single treatment has 
been identified for NAS.  This paper sought to analyze and synthesize research evaluating the 
effectiveness of breastfeeding and rooming-in care on the need and length of pharmacologic 
treatment and length of hospital stay for neonates with NAS.  Twenty-six peer reviewed research 
articles published between 2006 and 2017 were selected from PubMed and CINAHL for 
analysis.  The studies focused on neonates with NAS born to mothers addicted to opioids or 
undergoing opioid maintenance treatment (OMT).  The studies reviewed included systematic 
reviews and research studies utilizing control and intervention groups in various countries with 
sample sizes ranging from 16 to 952 neonates.  Findings indicate that breastfeeding and 
rooming-in are effective for mild-moderate NAS whereas pharmacologic treatments are 
recommended for moderate-severe NAS.  In addition to these findings, this paper will discuss 
limitations faced while compiling research and the possibility for future research and 
implementation into practice. 
Keywords: neonatal abstinence syndrome, pregnancy, post-natal care, breastfeeding, rooming-
in care, length of stay, substance abuse, opioids 
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The Effect of Breastfeeding and Rooming-In Care on Neonatal Abstinence Syndrome 
         Over the last twenty years, there has been a significant rise in the number of pregnant 
women who are addicted to drugs, specifically opioids, during their pregnancy.  Concurrent with 
an escalation in opiate prescription abuse, there has been a five-fold increase in the occurrence of 
pregnant women using opiates from 2000 to 2009 (Forray, 2016).  As of 2012, a national survey 
found that illicit drugs were used by 5.9% of pregnant women in the United States (Forray, 
2016).  This has resulted in an equally significant rise in the number of neonates born with 
Neonatal Abstinence Syndrome (NAS), which is the result of the sudden cessation of fetal 
exposure to any substance abused by the mother during pregnancy (Kocherlakota, 2014).  
Because opioids mainly affect the central nervous system and gastrointestinal tract, common 
signs and symptoms of NAS in neonates include: irritability, increased wakefulness, high-
pitched crying, repeated yawning and sneezing, exaggerated deep tendon reflexes, increased 
muscle tone, tremors, seizures, inadequate feeding and weight gain, uncoordinated continuous 
sucking, and temperature instability (Hudak et al., 2012).  Between 2009 and 2012, the 
occurrence of NAS jumped from 3.4 to 5.8 per 1,000 hospital births in the United States (Patrick, 
Davis, Lehman, & Cooper, 2015).  Between 2004 and 2013, the incidence of NAS soared from 7 
to 27 out of every 1,000 Neonatal Intensive Care Unit (NICU) admissions (Raffaeli et al., 2017).  
According to Centers for Disease Control and Prevention (CDC), the rate of NAS increased five- 
fold from 2000 to 2013 (Barfield, Broussard, Yonkers, & Patrick, 2016).  In 2012, the CDC 
stated that every 25 minutes a neonate was born with NAS in the United States (Barfield et al., 
2016).  There were approximately 21,732 neonates identified with NAS in 2012 in the United 
States alone (Patrick et al., 2015). 
THE EFFECT OF BREASTFEEDING AND ROOMING-IN CARE ON NEONATAL            4                
         Mothers suffering from drug addiction during pregnancy generally live high risk 
lifestyles that lead to a variety of social, nutritional, physical, and mental health problems 
(Kocherlakota, 2014).  Social issues of pregnant addicts include participation in illegal activities, 
inability to access appropriate birth control, decreased likelihood of attending prenatal care visits, 
and an increased likelihood of smoking and drinking alcohol (Ashraf, Ashraf, Asif, & Basri, 
2016).  A nutritional issue common to pregnant addicts is malnourishment (Ashraf et al., 2016).  
Physical issues that are common among pregnant addicts include irregular menstruation, 
amenorrhea, anemia, hypertension, diabetes mellitus, heart disease, increased risk of infection, 
and inadequate oral hygiene (Ashraf et al., 2016).  Mental health issues among pregnant addicts 
include postpartum mood disorders and depression (Pritham, 2013).  Due to these issues, women 
addicted to opioids during their pregnancy have six times the risk of developing obstetric 
complications, including abruptio placenta, premature rupture of membranes, preterm delivery, 
preeclampsia, and postpartum hemorrhage (Ashraf et al., 2016).  Additionally, maternal drug 
addiction puts the neonate at risk for intrauterine growth restriction, congenital anomalies, 
cognitive defects, prematurity, low birth weight, respiratory distress syndrome, and NAS (Ashraf 
et al., 2016; Raffaeli et al., 2017).  These complications of maternal and neonatal lifestyle result 
in an increased need for pharmacologic treatment, increased length of hospital stay (LOS), and 
increased medical costs (Raffaeli et al., 2017).  Due to increased cost of care and increased LOS, 
it was estimated that hospital charges for NAS care in 2012 was $1.5 billion (Crook & Brandon, 
2017). 
With a rise in neonates born with NAS, it is important for nurses to be prepared to use 
evidence-based practice to effectively care for neonates born with NAS.  The current issue 
nurses are facing is that there are heterogeneous standards of care across hospitals globally for 
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treating neonates with NAS.  According to Kocherlakota (2014), there is no single standard 
treatment regimen accepted for NAS due to the complicated and indistinct nature of withdrawal 
in neonates and the effects of illicit drugs.  Because thorough research has not been performed to 
determine the most effective treatment for NAS, nurses are left to treat neonates based on 
individual hospital policy rather than on what is best for the neonate.  By initiating a standard 
plan of care founded on evidence-based practice across hospitals globally, there is potential to 
improve patient outcomes and decrease healthcare costs. 
         In order to establish a foundation for evidence-based practice, it is important to identify 
which treatments are currently in practice, including pharmacologic and nonpharmacologic 
interventions.  Three common pharmacologic interventions used to treat NAS are morphine, 
methadone, and buprenorphine.  These substances are all opioids, which consist of endogenous 
and synthetic drugs that mainly act on opioid receptors in the central nervous system to elicit 
analgesia (Hudak et al., 2012).  Both morphine and methadone are opioid agonists and 
buprenorphine is an opioid mixed agonist-antagonist (Hudak et al., 2012).  These opioids have 
each been used to treat NAS in neonates, but morphine is currently the preferred treatment 
(Kocherlakota, 2014).  Neonates who receive pharmacologic treatment have an average LOS of 
23 days (Patrick et al., 2015).  Two common nonpharmacologic interventions used to treat NAS 
are breastfeeding and rooming-in care.  Breastfeeding (the feeding of milk produced by the 
mother to her neonate) and rooming-in care (the method of tending to both mother and baby in 
the same room beginning directly after birth) have both been identified as treatments that 
decrease the severity of NAS symptoms in neonates (Abrahams, MacKay-Dunn, Nevmerjitskaia, 
MacRae, Payne & Hodgson, 2010; Kocherlakota, 2014). 
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The aim of this systematic review is to clarify what is known about the effect of 
breastfeeding and rooming-in care on the need for pharmacologic treatment, length of 
pharmacologic treatment, and length of hospital stay with neonates suffering from NAS.  This 
systematic review is guided by the following question: In neonates with NAS, what is the 
effectiveness of nonpharmacologic interventions (including breastfeeding and rooming-in care) 
instead of or in addition to pharmacologic interventions such as opioid maintenance treatment 
(OMT) compared to exclusive OMT on decreasing the need for pharmacologic treatment, length 
of pharmacologic treatment, and length of hospital stay? 
Methods 
The search focused on research studies about neonates with NAS.  The mothers described 
in these studies were either currently addicted to opioids and other addictive substances or 
undergoing OMT.  The studies included both pharmacologic and non-pharmacologic 
interventions, including morphine maintenance treatment, buprenorphine maintenance treatment, 
methadone maintenance treatment, breastfeeding, and/or rooming-in care.  The timeline 
observed in these studies included the treatment of NAS in neonates from time of birth to 
discharge from a healthcare facility.  The studies were published in peer reviewed medical 
journals published between 2006 and 2017 found through CINAHL and PubMED databases. 
When searching the CINAHL and PubMED databases for research studies, the following 
keywords were used in a variety of combinations: neonatal abstinence syndrome, breastfeeding, 
rooming-in care, drug therapy, opioid maintenance treatment, methadone maintenance treatment, 
methadone, buprenorphine, and nonpharmacologic treatment.  Seventeen results were found 
when the keywords neonatal abstinence syndrome, breastfeeding, and opioid maintenance 
treatment were collectively searched on PubMed.  Fifty-two results were found when neonatal 
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abstinence syndrome, breastfeeding, and drug therapy were collectively searched on PubMed.  
Two results were found when neonatal abstinence syndrome, rooming-in care, and opioid 
maintenance treatment were collectively searched on PubMed.  Eight results were found when 
neonatal abstinence syndrome and rooming-in care were collectively searched on PubMed.  One 
hundred and one results were found when neonatal abstinence syndrome and buprenorphine were 
collectively searched on CINAHL.  Six results were found when neonatal abstinence syndrome 
and rooming-in care were collectively searched on CINAHL. 
After each initial keyword search brought back a list of search results, studies from that 
results list were first eliminated if the title of the study was irrelevant to the treatment of neonates 
with NAS.  If the studies were still relevant, their abstracts were examined to determine if the 
content of the study was relevant to the treatment of neonates with NAS.  If the studies were 
irrelevant, they were discarded; if the studies were relevant, their entire contents were thoroughly 
read to determine if the studies examined how each NAS treatment affected the outcomes 
described in the research question.  The outcomes described in the research question include the 
need for pharmacologic treatment, length of pharmacologic treatment, and length of hospital stay 
for neonates suffering from NAS.  If one or all of these outcomes were measured, the study was 
included in this systematic review.  In total, twenty-six research studies met the criteria 
previously stated and were included in this systematic review. 
The journals used in this review were selected based on their relevance to the keywords 
and if they met the criteria established before conducting the research.  The use of the two 
databases CINAHL and PubMed ensured a comprehensive review of available studies related to 
the topic at hand.  This review sought to avoid bias by including studies with multiple points of 
THE EFFECT OF BREASTFEEDING AND ROOMING-IN CARE ON NEONATAL            8                
view about the effectiveness of nonpharmacologic and pharmacologic treatments used to treat 
NAS. 
Results 
There were twenty-six research studies included in this systematic review.  This section 
will provide detailed information on the sample setting, sampling method, sample size, study 
design, level of evidence, and specific findings of the research studies included in this systematic 
review.  The specific findings will describe the conclusions reached regarding the need for 
pharmacologic treatment, length of pharmacologic treatment, and length of hospital stay. 
Sample Setting 
An extensive review of the literature revealed that studies about nonpharmacologic 
treatments for neonates with NAS have been conducted across the globe.  Included within this 
systematic review are two studies from Australia, two from the United Kingdom, six from 
Canada, six from the United States, and one from Norway.  Considering the worldwide interest 
in this neonatal health problem, nurses should seek out research that supports effective evidence-
based practices to care for neonates born with NAS. 
Two studies were performed at hospitals in Australia, with one study located in 
Randwich, New South Wales and one study located in Western Sydney (Abdel-Latif et al., 2006; 
Liu, Juarez, Nair, & Nanan, 2015).  Two studies were performed at hospitals in the United 
Kingdom, with one performed in London and the other in Glasgow (Dryden, Young, Hepburn & 
Mactier, 2009; Saiki, Lee, Hannam & Greenough, 2010).  One study looked at 18 different 
hospitals in Norway (Welle-Strand, Skurtveit, Jansson, Bakstad, Bjarkø & Ravndal, 2013). 
Six studies were performed at hospitals in Canada.  Three of the six studies were 
performed in Vancouver, one of which was specifically performed at the Fir Square Unit of BC 
THE EFFECT OF BREASTFEEDING AND ROOMING-IN CARE ON NEONATAL            9                
Women’s Hospital (Abrahams, Kelly, Payne, Thiessen, Mackintosh & Janssen, 2007; Abrahams 
et al., 2010; Hodgson & Abrahams, 2012).  One of the six studies was performed at hospitals in 
Vancouver, Toronto, and Montreal (Ordean, Kahan, Graves, Abrahams & Kim, 2015).  Two of 
the six studies were specifically performed at Kingston General Hospital in Ontario (McKnight 
et al., 2015; Newman et al., 2015).  
Five studies were performed at hospitals in the United States.  Four of the five studies 
were located in the northeastern states, including Pennsylvania, New York, New Hampshire, and 
Maine (Brown, Hayes & Thornton, 2015; Holmes et al., 2016; Kraft et al., 2008; Kraft et al., 
2017).  The two studies located in Pennsylvania were both conducted at the Thomas Jefferson 
University Hospital (Kraft et al., 2008; Kraft et al., 2017).  One of the five studies was located in 
the Midwest state of Ohio (Isemann, Meinzen-Derr & Akinbi, 2011). 
Five studies were systematic reviews that pulled the research necessary for their reviews 
from several online databases, including PubMed, Ovid Medline, Embase, CINAHL, Medline, 
and Cochrane (Bagley, Wachman, Holland, & Brogly, 2014; Boucher, 2017; Holmes, Schmidlin 
& Kurzum, 2017; Kocherlakota, 2014; Pritham, 2013).  Four studies were performed at 
unspecified hospitals, clinics, or treatment programs (Crook & Brandon, 2017; Hudak et al., 
2012; Jansson et al., 2008; O’Connor, Collett, Alto & O’Brien, 2013).  One study was a 
compilation of current medical research and expert opinion discussing NAS (Raffaeli et al., 
2017).  Given the national and international interest in this topic at prestigious institutions, 
synthesis of study results and further research is certainly warranted. 
Sampling Method 
Among the 26 studies included in this systematic review, a common methodology is 
evident with noticeable similarities and differences.  The overwhelming majority of studies 
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utilized a control group compared with one or more intervention groups.  The minority of studies 
used databases to synthesize evidence from research studies to draw a conclusion about the 
effectiveness of one or more interventions. 
Fourteen studies followed two comparison groups during a specific length of time.  
However, these 14 studies did not use the same type of comparison groups or conduct research 
during the same time periods.  Seven of the 14 studies used a comparison group of formula-fed 
neonates with a comparison group of breastfed neonates suffering from NAS (Abdel-Latif et al., 
2006; Dryden et al., 2009; Isemann et al., 2011; Jansson et al., 2008; Liu et al., 2015; O’Connor 
et al., 2013; Welle-Strand et al., 2013).  Three of the 14 studies used a comparison group of 
neonates with NAS rooming-in with their mothers and a comparison group of neonates with 
NAS admitted to the NICU (Abrahams et al., 2010; Newman et al., 2015; Ordean et al., 2015).  
One of the 14 studies specifically used a comparison group with and a control group without 
prenatal family education, increased family involvement in symptom monitoring as well as in 
nonpharmacologic treatment, and rooming-in care (Holmes et al., 2016).  One of the 14 studies 
used a comparison group of neonates with NAS who received buprenorphine and a comparison 
group of neonates with NAS who received morphine (Kraft et al., 2017).  One of the 14 studies 
used a comparison group of neonates with NAS who received methadone and a comparison 
group of neonates with NAS who received morphine (Brown et al., 2015).  One of the 14 studies 
used a comparison group of neonates with NAS who received buprenorphine and a comparison 
group of neonates with NAS who received neonatal opium solution (NOS) (Kraft et al., 2008). 
Three research studies used two comparison groups in which both groups collected data 
at different periods of time.  These three studies used the same type of control and comparison 
groups, but did not conduct the research over the same time periods.  The control group consisted 
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of a group of neonates suffering from NAS who were admitted to the NICU, while the 
comparison group consisted of neonates with NAS that practiced rooming-in with their mothers 
(Abrahams et al., 2007; McKnight et al., 2015; Saiki et al., 2010). 
One research study looked at one cohort over a specific length of time (Hodgson & 
Abrahams, 2012).  The cohort was made up of mother-neonate dyads who were cared for 
through a rooming-in care program.  The medical charts of these dyads were reviewed and data 
was collected regarding the type of drug used by the mother, maternal methadone dose at the 
time of delivery, and whether or not the neonate required morphine treatment. 
One research study used three comparison groups in which each comparison group had 
data collected at different periods of time.  This study used a comparison group of neonates with 
NAS before specific changes in interventions occurred, a comparison group after Baby Friendly 
Status (BFS) was implemented, and a comparison group after BFS plus breastfeeding education 
was implemented (Crook & Brandon, 2017).  Baby Friendly Status in this particular study is 
defined as a quality improvement program which promotes breastfeeding through the healthcare 
structure and practices (Crook & Brandon, 2017).  There are ten steps involved in achieving 
BFS, some of these include: allowing mothers and neonates to remain together 24 hours a day, 
training the staff how to implement this policy, encouraging breastfeeding on neonate command, 
and giving neonates no drinks other than breast milk (Crook & Brandon, 2017). 
Five of the studies were systematic reviews.  These studies used databases to find 
research articles relating to the topic at hand.  The keywords used to find the studies for these 
five studies included, but were not limited to, LOS, breastfeeding, nonpharmacologic treatment, 
rooming in, swaddling, and NAS (Bagley et al., 2014; Boucher, 2017; Holmes et al., 2017; 
Kocherlakota, 2014; Pritham, 2013). 
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Two of the studies simply compiled current scientific literature on the subject of NAS 
(Hudak et al., 2012; Raffaeli et al., 2017).  Topics described in these studies included clinical 
presentation, diagnostic strategies, and types of nonpharmacologic and pharmacologic therapy.    
Most importantly, these studies weighed current evidence to determine when treating NAS with 
pharmacologic therapies is necessary.  The current work in this area is based on research using 
strong methodology.  Therefore, the studies provide a good basis for developing policy and 
interventions. 
Sample Size 
Fourteen studies followed two comparison groups during a specific length of time.  For 
seven of the 14 studies, which used a group of formula-fed neonates and a group of breastfed 
neonates, the sample size ranged from 16 to 437 neonates (Abdel-Latif et al., 2006; Dryden et 
al., 2009; Isemann et al., 2011; Jansson et al., 2008; Liu et al., 2015; O’Connor et al., 2013; 
Welle-Strand et al., 2013).  For three of the 14 studies, which used a group of neonates who 
roomed-in with their mothers and a group of neonates who were admitted to the NICU, the 
sample size ranged from 45 to 952 neonates (Abrahams et al., 2010; Newman et al., 2015; 
Ordean et al., 2015).  For one of the 14 studies, which used a group with neonates that received 
pharmacologic treatment and a group with neonates that received nonpharmacologic treatment, 
the total sample size was 163 neonates with 69 receiving pharmacologic treatment and 94 
receiving nonpharmacologic treatment (Holmes et al., 2016).  For one of the 14 studies, which 
used a group of neonates who received buprenorphine and a group of neonates who received 
morphine, the total sample size was 63 neonates with 33 receiving buprenorphine and 30 
receiving morphine (Kraft et al., 2017).  For one of the 14 studies, which used a group of 
neonates who received methadone and a group of neonates who received morphine, the total 
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sample size was 31 neonates with 15 receiving methadone and 16 receiving morphine (Brown et 
al., 2015).  For one of the 14 studies, which used a group of neonates who received 
buprenorphine and a group of neonates who received neonatal opium solution (NOS), the total 
sample size was 26 neonates with 13 receiving buprenorphine and 13 receiving NOS (Kraft et 
al., 2008). 
Three research studies used two comparison groups in which both groups collected data 
at different periods of time.  The control group consisted of a group of neonates suffering from 
NAS who were admitted to the NICU, while the comparison group consisted of neonates with 
NAS that practiced rooming-in with their mothers.  The sample size ranged from 44 to 96 
neonates (Abrahams et al., 2007; McKnight et al., 2015; Saiki et al., 2010). 
One research study looked at one cohort over a specific length of time (Hodgson & 
Abrahams, 2012).  The cohort was made up of mother-neonate dyads who were cared for 
through a rooming-in care program.  The total sample size for this study was 295 neonates. 
One research study used three comparison groups in which each comparison group had 
data collected at different periods of time.  This study used a comparison group of neonates with 
NAS before specific changes in interventions occurred, a comparison group after Baby Friendly 
Status (BFS) was implemented, and a comparison group after BFS plus breastfeeding education 
was implemented (Crook & Brandon, 2017).  The total sample size of this study was 200 
neonates. 
Five of the studies used databases to find research articles relating to the topic at hand 
(Bagley et al., 2014; Boucher, 2017; Holmes et al., 2017; Kocherlakota, 2014; Pritham, 2013).  
The sample size ranged from 5 to 13 articles included within each systematic review.  Two of the 
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five studies stated that many articles were included within each systematic review, but failed to 
state a specific sample size. 
Two of the studies simply compiled current scientific literature on the subject of NAS 
(Hudak et al., 2012; Raffaeli et al., 2017).  The first study cited a total of 165 journal articles 
(Hudak et al., 2012).  The second study cited a total of 64 journal articles (Raffaeli et al., 2017).  
These studies utilized a range of sample sizes to create a strong foundation upon which future 
research can be conducted. 
Design and Level of Evidence 
While conducting a systematic review, it is important that well designed studies are used 
in the analyses.  Five types of designs were identified after reviewing the studies included in this 
review: systematic reviews, randomized controlled trials, controlled trials without randomization, 
retrospective cohort studies, and expert opinions.  These designs are ranked on predetermined 
scales and the strength of the evidence is graded using three areas of expertise: quality, quantity, 
and consistency (Schmidt & Brown, 2015). 
Systematic reviews are marked as a level one evidence because they combine the results 
of studies and statistically determine the effects of the interventions used (Schmidt & Brown, 
2015).  These types of studies often use both published and unpublished studies (Schmidt & 
Brown, 2015).  Five of the studies were systematic reviews (Bagley et al., 2014; Boucher, 2017; 
Holmes et al., 2017; Kocherlakota et al., 2014; Pritham, 2013). 
Randomized controlled trials are marked as a level two evidence.  Three of the studies 
included in this systematic review were randomized controlled trials (Brown et al., 2015; Kraft et 
al., 2008; Kraft et al., 2017).  Controlled trials without randomization are marked as a level three 
evidence.  Four of the studies were controlled trials without randomization (Crook & Brandon, 
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2017; Holmes et al., 2016; Jansson et al., 2008; Newman et al., 2015).  Both of these types of 
trials can be found in nursing literature and help with the promotion of evidence-based practice 
(Schmidt & Brown, 2015). 
Retrospective cohort studies are marked as a level four evidence.  They look at changes 
in characteristics of a large sample over time (Schmidt & Brown, 2015).  Twelve of the studies 
were retrospective cohort studies (Abdel-Latif et al., 2006; Abrahams et al., 2007; Abrahams et 
al., 2010; Dryden et al., 2009; Hodgson & Abrahams, 2012; Isemann et al., 2011; Liu et al., 
2015; McKnight et al., 2015; O’Connor et al., 2013; Ordean et al., 2015; Saiki et al., 2010; 
Welle-Strand et al., 2013).  Expert opinions are marked as a level seven evidence.  Two of the 
studies were considered expert opinions (Hudak et al., 2012; Raffaeli et al., 2017).  Although 
these studies range from strongly designed randomized controlled trials to expert opinion, each 
study adds to the knowledge amassed in this systematic review and helps researchers better 
understand NAS. 
Findings  
 This section will describe the specific findings related to the effectiveness of treatments 
for NAS.  Both nonpharmacologic and pharmacologic treatments will be discussed, including 
breastfeeding, rooming-in care, morphine, methadone, and buprenorphine.  Each of these 
treatments will be examined to determine how they affect the need for pharmacologic treatment, 
length of pharmacologic treatment, and length of hospital stay. 
Breastfeeding. 
Of the 28 studies examined in this systematic review, similar findings related to 
breastfeeding neonates suffering from NAS were identified.  A correlation between breastfeeding 
and a decrease in the severity of NAS in neonates was found in seven of the studies reviewed 
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(Abdel-Latif et al., 2006; Bagley et al., 2014; Dryden et al., 2009; Hudak et al., 2012; Isemann et 
al., 2011; O’Connor et al., 2013; Pritham, 2013).  Two of these seven studies found that 
breastfeeding decreased Finnegan scores, one specifying that the mean score peak decreased 
from 9.65 to 8.8 (Bagley et al., 2014; O’Connor et al., 2013).  The Finnegan scoring system was 
created in 1975 as a neonatal narcotic withdrawal scoring system (Bagley et al., 2014).  It 
includes 20 items, such as high pitched cries, feeding habits, stools, and is weighted on 
pathologic severity (Bagley et al., 2014).  The higher the score, the more severe the NAS is 
considered. 
One study that showed a correlation between breastfeeding and the severity of NAS in 
neonates was a systematic review with an objective to provide findings related to the assessment 
and management of neonates with NAS (Bagley et al., 2014).  A total of 13 studies regarding 
nonpharmacologic interventions were included in the review with seven studies specifically 
examining the relationship between the neonate feeding method and NAS outcomes (Bagley et 
al., 2014).  The articles were found on PubMed and Cochrane Databases and were published 
between 1975 and 2013 (Bagley et al., 2014).  Since the transfer of methadone and 
buprenorphine through breastmilk is minimal, breastfeeding is recommended for mothers on 
opioid maintenance therapy, but it is not recommended for mothers using illicit drugs (Bagley et 
al., 2014).  The review shared how breastfeeding is found to act as an analgesic for neonates 
(Bagley et al., 2014).  Throughout examination of the studies, it was concluded that 
predominantly breastfed neonates showed a decrease in Finnegan scores as early as the first nine 
days of life when compared to formula fed neonates (Bagley et al., 2014).  The average Finnegan 
scores in breastfed neonates compared to formula fed neonates was not calculated in this study. 
LOS was shown to decrease by up to 19 days in breastfed neonates, and breastfed neonates had a 
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30% decreased need for pharmacologic treatment (Bagley et al., 2014).  The correlation of 
breastfeeding and the decreased need for pharmacologic treatment and LOS will be discussed in 
further detail in this section. 
Eleven studies found that breastfeeding decreases the neonate’s need for pharmacologic 
treatment (Abdel-Latif et al., 2006; Bagley et al., 2014; Dryden et al., 2009; Holmes et al., 2017; 
Hudak et al., 2012; Jansson et al., 2008; Kocherlakota, 2014; Liu et al., 2015; O’Connor et al., 
2013; Pritham, 2013; Welle-Strand et al., 2013).  The result of one of those studies was not 
statistically significant due to a small sample size.  Of these 11 studies, seven stated that there 
was a decrease in the need for pharmacological treatment in breastfed neonates ranging from 
6.9% to 50% compared to formula fed neonates (Abdel-Latif et al., 2006; Bagley et al., 2014; 
Dryden et al., 2009; Holmes et al., 2017; Liu et al., 2015; O’Connor et al., 2013; Welle-Strand et 
al., 2013). 
Three studies found that breastfeeding decreased the length of pharmacologic treatment 
in neonates with NAS (Abdel-Latif et al., 2006; Isemann et al., 2011; Welle-Strand et al., 2013).  
One of these three studies stated that the length of methadone maintenance therapy in a neonate 
would decrease from 15 to 8 days if that neonate was breastfed (Isemann et al., 2011).  Another 
of the three studies stated that the length of pharmacologic treatment in neonates who were 
breastfed was 28.6 days compared to 46.7 days in neonates who were formula fed (Welle-Strand 
et al., 2013). 
If the need for and length of pharmacologic treatment both decreased, LOS would also 
decrease.  This finding was shown by eight studies which indicated that breastfeeding reduces 
the neonate’s LOS (Abdel-Latif et al., 2006; Bagley et al., 2014; Crook & Brandon, 2017; 
Dryden et al., 2009; Holmes et al., 2017; Isemann et al., 2011; Kocherlakota, 2014; Pritham, 
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2013).  Of these eight studies, five stated that the LOS for breastfed neonates with NAS 
compared to formula fed neonates with NAS decreased between 2.3 days and 19 days (Abdel-
Latif et al., 2006; Bagley et al., 2014; Crook & Brandon, 2017; Holmes et al., 2017; Isemann et 
al., 2011). 
One study included a quality improvement project to see whether prenatal breastfeeding 
initiatives would increase breastfeeding rates and decrease LOS in neonates with NAS (Crook & 
Brandon, 2017).  The study included three groups: a traditional care group that included births 
from February 2014 to August 2014; a baby friendly status (BFS) group that included births 
from September 2014 to January 2015; and a BFS plus breastfeeding education group that 
included births from February 2015 to July 2015.  Hospital achieved BFS means that the facility 
provides great care for neonate feeding as well as mother-neonate bonding.  LOS was 18.8 days 
in the traditional care group, 13.14 days in the BFS group, and 10.41 days in the BFS plus 
breastfeeding education group.  Breastfeeding initiation rates were higher in women who were 
part of group care as opposed to traditional prenatal care.  Sixty-seven point three percent of 
neonates in the traditional care group needed pharmacologic treatment, 53.9% of neonates in the 
BFS group needed pharmacologic treatment, and 34.8% of neonates in the BFS plus 
breastfeeding education group needed pharmacologic treatment (Crook & Brandon, 2017).  
These results demonstrate that detailed breastfeeding education should be provided to all mothers 
with neonates suffering from NAS (Crook & Brandon, 2017). 
In opposition to all previous findings, one study stated there is no benefit to breastfeeding 
neonates with NAS in regards to NAS scores and the need for pharmacologic treatment (Liu et 
al., 2015).  The study stated that breastfed neonates were found to have an average NAS score of 
1.3 compared to formula fed neonates who had an average NAS score of 1.1 (Liu et al., 2015).  
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The study also found that the max dose of morphine required was the same for breastfed 
neonates as formula fed neonates, which was 0.5-0.7 milligrams per kilogram per day (Liu et al., 
2015).  This study had a small sample size as well as other limitations that could have affected its 
results.  While it is possible the findings of this study could be supported by future research, this 
study alone should not lead to the conclusion that breastfeeding is a poor treatment option for 
neonates with NAS. 
Overall, these studies indicate that breastfeeding decreases NAS severity, decreases the 
need and length of pharmacologic treatment, and decreases LOS.  Due to these positive findings, 
it was also determined that breastfeeding education should be provided to all mothers with 
neonates suffering from NAS. 
Rooming-in care. 
Out of the 26 studies used in this systematic review, several of the studies provided 
findings related to rooming-in care and how it affects neonates with NAS.  Seven studies found 
that rooming-in care decreases the need for pharmacologic treatment (Abrahams et al., 2007; 
Boucher, 2017; Hodgson & Abrahams, 2012; McKnight et al., 2015; Newman et al., 2015; 
Ordean et al., 2015; Saiki et al., 2010), with one study specifying that rooming-in care decreases 
the need for oral morphine therapy (Abrahams et al., 2007).  These seven studies examined how 
the need for pharmacologic treatment differed between neonates who roomed-in with their 
mothers or were cared for in the NICU.  The percentage of neonates who needed pharmacologic 
treatment in rooming-in ranged from 11% to 79.2%, whereas the percentage of neonates who 
needed pharmacologic treatment who were cared for in the NICU ranged from 45% to 88.7% 
(Abrahams et al., 2007; Boucher, 2017; Hodgson & Abrahams, 2012; McKnight et al., 2015; 
Newman et al., 2015; Ordean et al., 2015; Saiki et al., 2010).  Overall, the percentage of neonates 
THE EFFECT OF BREASTFEEDING AND ROOMING-IN CARE ON NEONATAL            20                
who needed pharmacologic treatment was lower by a statistically significant number for those 
who roomed-in with their mothers. 
Four studies found that rooming-in care decreases the length of pharmacologic treatment 
in neonates with NAS (Abrahams et al., 2007; Bagley et al., 2014; Boucher, 2017; Saiki et al., 
2010).  These four studies examined the length of pharmacologic treatment in neonates who 
roomed-in with their mothers compared to those cared for in the NICU.  The length of 
pharmacologic treatment for neonates who roomed-in with their mothers ranged from 5.9 to 27 
days, whereas the length of pharmacologic treatment for neonates cared for in the NICU ranged 
from 18.6 to 32.5 days (Abrahams et al., 2007; Bagley et al., 2014; Boucher, 2017; Saiki et al., 
2010).  Overall, the length of pharmacologic treatment was lower by a statistically significant 
number for neonates who roomed-in with their mothers. 
When the length of pharmacologic treatment decreases for a neonate with NAS, the 
length of hospital stay has also been shown to decrease.  Seven studies found that rooming-in 
care reduces the neonate’s LOS (Abrahams et al., 2007; Bagley et al., 2014; Boucher, 2017; 
Holmes et al., 2016; McKnight et al., 2015; Newman et al., 2015; Saiki et al., 2010).  Six of the 
seven studies compared the LOS in neonates who roomed-in with their mothers and those who 
were cared for in the NICU.  Between these specific six studies, the mean LOS for neonates who 
roomed-in with their mothers was 12.6 days, whereas the mean LOS for neonates cared for in the 
NICU was 25 days (Abrahams et al., 2007; Boucher, 2017; Holmes et al., 2016; McKnight et al., 
2015; Newman et al., 2015; Saiki et al., 2010). 
In contrast, two studies found that rooming-in care increases the neonate’s LOS 
(Abrahams et al., 2010; Ordean et al., 2015).  One of these two studies stated that LOS for 
neonates who roomed-in with their mothers was 21 days, whereas LOS for neonates who were 
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cared for in the NICU was 11 days (Abrahams et al., 2010).  The other study found that LOS for 
neonates who roomed-in with their mothers was 26 days, whereas LOS for neonates who did not 
room-in with their mothers was between 14 and 16 days (Ordean et al., 2015). 
One specific retrospective cohort study examined rooming-in for neonates with NAS 
across three comparison groups (Abrahams et al., 2007).  The first group consisted of 32 
neonates who roomed-in with their mothers at Vancouver General Hospital during October 2001 
and December 2002 (Abrahams et al., 2007).  The second group consisted of 28 neonates who 
were admitted to a level two nursery at B. C. Women’s Hospital between January 1999 and 
September 2001 (Abrahams et al., 2007).  The third group consisted of 36 neonates who were 
admitted to a level two nursery at Surrey Memorial Hospital between January 1999 and 
December 2002 (Abrahams et al., 2007).  Results from this study showed that rooming-in care 
was associated with decreased need for pharmacologic treatment with morphine, length of 
pharmacologic treatment, and LOS.  Only 25% of the neonates that roomed-in needed 
pharmacologic treatment, whereas between 52.8% and 55.3% of neonates admitted to a level two 
nursery needed pharmacologic treatment (Abrahams et al., 2007).  The length of pharmacologic 
treatment with morphine for neonates who roomed-in with their mothers was 5.9 days compared 
to 18.6 days for neonates admitted to a level two nursery (Abrahams et al., 2007).  The LOS for 
neonates who roomed-in with their mothers was 11.8 days compared to an average of 24.7 days 
for neonates admitted to a level two nursery (Abrahams et al., 2007).  Besides two outlying 
studies that found rooming-in care increased LOS, the majority of studies indicate that rooming-
in care decreases the need for pharmacologic treatment, decreases the length of pharmacologic 
treatment, and decreases LOS. 
Pharmacologic treatments. 
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 Four studies regarding pharmacologic treatments for NAS were included in this 
systematic review (Brown et al., 2015; Kraft et al., 2008; Kraft et al., 2017; Raffaeli et al., 2017).  
It is crucial to examine the effects of pharmacologic treatments on neonates with NAS because 
50-80% of opiate-exposed neonates require some form of pharmacologic treatment (Raffaeli et 
al., 2017).  For example, the average LOS for neonates with NAS increases from 17 to 23 days 
when the neonate has to receive pharmacologic treatment (Raffaeli et al., 2017).  Therefore, it is 
important to examine each type of pharmacologic treatment in order to know how each of them 
affects a neonate’s LOS.  These four studies focus on three main pharmacologic treatments: 
buprenorphine, methadone, and morphine. 
Of the four studies regarding pharmacological, three of them focused on comparing 
buprenorphine treatments to other pharmacological agents, such as morphine and methadone 
(Kraft et al., 2008; Kraft et al., 2017; Raffaeli et al., 2017).  One of the three studies discussed 
the nature of the medications themselves, including the pros and cons of buprenorphine, 
methadone, and morphine (Raffaeli et al., 2017).  The study found that treating neonates with 
buprenorphine decreased the need for pharmacologic treatment, decreased the length of 
pharmacologic treatment by 40%, and decreased LOS by 24% when compared to treating 
neonates with morphine (Raffaeli et al., 2017).  The study also found that evidence regarding 
how methadone compared to morphine was conflicting and inconclusive (Raffaeli et al., 2017).  
Another one of the three studies showed that the length of pharmacologic treatment with 
buprenorphine is 13 days shorter than treatment with morphine (Kraft et al., 2017).  In addition, 
the same study found that the LOS for neonates receiving buprenorphine is 12 days shorter than 
for neonates receiving morphine (Kraft et al., 2017).  The last of the three studies compared 26 
term neonates with NAS who were randomly assigned to receive buprenorphine or neonatal 
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opium solution (NOS) (Kraft et al., 2008).  The results showed that the mean length of 
pharmacologic treatment in the morphine group was 32 days, whereas the mean length of 
pharmacologic treatment in the buprenorphine group was 22 days (Kraft et al., 2008).  
Additionally, the mean LOS for neonates treated with morphine was 38 days, whereas the mean 
LOS for neonates treated with buprenorphine was 27 days (Kraft et al., 2008).  Overall, these 
findings point to the conclusion that buprenorphine is a more effective pharmacologic treatment 
compared to methadone and morphine. 
One study compared methadone and morphine pharmacologic treatment in neonates with 
NAS (Brown et al., 2015).  A total of 31 neonates were randomly selected to receive either 
methadone or morphine (Brown et al., 2015).  The results showed that the length of 
pharmacologic treatment for neonates treated with methadone was 14 days, whereas the length of 
pharmacologic treatment for neonates treated with morphine was 21 days (Brown et al., 2015).  
Overall, the evidence points towards methadone being a more effective pharmacologic treatment 
than morphine. However, more research should be done to compare buprenorphine to 
methadone. 
Critical Appraisal of the Evidence 
 The following sections will examine the limitations of findings, the validity and 
reliability of the methods and findings, and the limitations across the studies included in this 
systematic review. 
Limitations of Findings 
 There are several notable limitations to the findings of this systematic review.  Due to the 
recent rise in illicit drug use and relative newness of NAS, only a small amount of research has 
been performed on NAS in general.  As a result, this systematic review was first limited by the 
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lack of general research on NAS and further limited by the small number of studies directly 
relevant to the aim of this systematic review.  Another limitation was only two databases were 
searched for relevant studies to include in the systematic review.  It is possible that more studies 
could have been found if databases in addition to PubMed and CINHAL were searched.  The 
findings of this systematic review were limited by the keywords chosen to search PubMed and 
CINHAL.  It is possible that using additional keywords and combinations of keywords that more 
studies could have been found.  Additionally, the studies selected were free to access by 
downloading and reading online PDF versions of the studies.  More studies could have 
potentially been included if interlibrary loan, paid sources of research, and physical forms of 
research were investigated. 
Validity and Reliability of the Methods and Findings 
 Across the studies included in this systematic review, issues have been discovered with 
the validity and reliability of the methods and findings.  In three studies, the Finnegan scoring 
tool was either used incorrectly or subjectively depending on which healthcare professional was 
using the scoring tool (Abdel-Latif et al., 2006; Kraft et al., 2008; Newman et al., 2015).  In one 
study, there were a high number of premature neonates included in the study population, which 
could have skewed the reliability of the study (Abdel-Latif et al., 2006).  Three studies noted that 
not all of the hospitals they gathered data from used the same list of signs and symptoms to 
diagnose a neonate with NAS (Abrahams et al., 2010; Newman et al., 2015; Welle-Strand et al., 
2013).  Thus, the validity of the methods of these studies is decreased because there could have 
been more or less neonates diagnosed with NAS depending on which list of signs and symptoms 
were used.  Two studies stated they did not know which types of illicit drugs the mothers took 
during pregnancy and how those different drugs could have affected the severity of NAS in the 
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neonates as a result (Abrahams et al., 2010; McKnight et al., 2015).  Therefore, the validity of 
the findings of these studies is decreased because it is possible that breastfeeding and rooming-in 
were more successful in treating NAS since the illicit drugs the mothers were on had less severe 
effects on the neonates.  Two studies noted that the validity of their methods was compromised 
because there were inconsistencies and/or omissions in their data collection due to 
documentation issues in patient charts (Isemann et al., 2011; Ordean et al., 2015).  One study 
stated their results may not be universally applicable to pregnant women because the 
effectiveness of rooming-in may have been affected by whether or not pregnant women received 
prenatal care (Ordean et al., 2015).  One study stated the validity of their methods may have been 
affected because they used a limited number of attending pediatricians to care for their patients 
(Holmes et al., 2016).  This means that the methods these pediatricians used to care for neonates 
with NAS could have negatively affected the outcomes examined in the study.  One study noted 
the validity of their findings could have been affected because the use of methadone or 
buprenorphine maintenance treatments on top of rooming-in care could have masked the true 
effects rooming-in care has on neonates with NAS when used on its own (Holmes et al., 2016).  
One study stated the reliability of their methods could have been affected because they compared 
sample groups of different sizes (Abrahams et al., 2007).  The same study noted the reliability of 
their findings could have been affected because they were unable to separate out the specific 
effects of breastfeeding from the effects of rooming-in care (Abrahams et al., 2007). 
Limitations across Studies 
Upon reviewing the studies included in this systematic review, several limitations were 
found to be issues across the studies.  Three major limitations found across the studies included 
no randomized group assignment (Abdel-Latif et al., 2006; Abrahams et al., 2007; Boucher, 
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2017; McKnight et al., 2015; O’Connor et al., 2013; Ordean et al., 2015; Saiki et al., 2010), no 
use of control over the study (Boucher, 2017; Kraft et al., 2008; McKnight et al., 2015; 
O’Connor et al., 2013; Ordean et al., 2015), and small study population (Brown et al., 2015; 
Crook & Brandon, 2017; Jansson et al., 2008; Kraft et al., 2017; Liu et al., 2015; McKnight et 
al., 2015; O’Connor et al., 2013).  Other limitations found across the studies include not 
accounting for outside variables (Abrahams et al., 2010; O’Connor et al., 2013), not being able to 
differentiate between the positive effects of breastfeeding and the effects of skin-to-skin contact 
during breastfeeding (O’Connor et al., 2013), not knowing how long mothers breastfed their 
neonates with NAS (Bagley et al., 2014; Welle-Strand et al., 2013), only gathering data from one 
hospital (Brown et al., 2015; Kraft et al., 2008; Kraft et al., 2017), and not using an ethnically 
diverse sample population (Brown et al., 2015).  These limitations represent areas where those 
conducting the studies failed to ensure the validity and reliability of their study.  These areas of 
failure should be improved upon with research conducted on NAS in the future. 
Recommendations 
After an extensive review of twenty-six studies, potential practice and research 
implications were determined for future studies that may be conducted.  Research findings 
support breastfeeding and rooming-in care as effective treatments for mild to moderate cases of 
NAS.  Results of the studies show that breastfeeding and rooming-in care decrease the need for 
pharmacologic treatment, length of pharmacologic treatment, and length of hospital stay.  In 
moderate to severe cases, it is recommended that nonpharmacologic treatments be used in 
combination with pharmacologic treatments.  Combining these two treatments will provide the 
most effective care in treating NAS symptoms.  Three studies showed that methadone is more 
effective than morphine as a pharmacologic treatment for NAS, however more research should 
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be done to compare buprenorphine to methadone (Kraft et al., 2008; Kraft et al., 2017; Raffaeli 
et al., 2017).    
As previously noted, an issue facing nurses today is the heterogeneous standards of care 
across hospitals globally for treating neonates with NAS.  It is recommended that hospitals and 
healthcare facilities look further into case studies and the possibility of implementing a standard 
treatment protocol for opioid-dependent neonates with NAS derived from evidence-based 
practice.  Once a standard treatment for NAS is created, it is important to first implement the 
standard care locally before advancing to a regional or statewide practice.  At a local level, it 
would be easier to implement any changes needed to be done to the standard treatment for NAS 
before it becomes a regional or statewide practice.  In addition, it is recommended that doctors, 
nurses, and other healthcare professionals be further educated about the treatment and care of 
neonates with NAS.  It is important to have well-informed staff members that use evidence-
based practice to effectively care for their patients. 
Next, it is recommended that research be done to develop a standard screening process 
for neonates who are at risk for developing NAS and expecting mothers who have a history or 
high risk of substance abuse.  Along with this new standard of care and screening process, it is 
recommended that the mothers of opioid-dependent neonates be encouraged to take part in an 
educational program to teach them the importance of nonpharmacologic practices such as 
breastfeeding and rooming-in care and the positive impact they have on their child’s health 
outcomes.  These educational programs should also teach mothers who still struggle with 
substance abuse and addiction how important it is to stop breastfeeding.  The transfer of 
methadone and buprenorphine through breast milk is minimal.  Therefore, breastfeeding is 
recommended for mothers on opioid maintenance therapy, but it is not recommended for mothers 
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using illicit drugs (Bagley et al., 2014).  These educational programs could be offered in local 
hospitals as well as in the community.  It is recommended that medical treatment, resources, and 
teaching are made available for mothers to stop abuse of illicit substances. 
Finally, it is recommended that further research be done on treatment for NAS to advance 
future practice.  Larger, more inclusive studies would be beneficial to determine the trends and 
common practices for dealing with cases of NAS.  One option would be to conduct more 
randomized controlled clinical trials as opposed to retrospective studies in order to obtain a more 
accurate comparison of effective treatment plans.  Another option would be to conduct a 
comprehensive focused review concerning the current standards of care for NAS patients at 
various local and state institutions to determine which treatments prove to be most effective for 
relieving symptoms of withdrawal with the least negative consequences.  This review could 
include current as well as previous patient charts and their treatment plans.  Further systematic 
reviews would also be beneficial to accumulate data that is currently available for both 
pharmacologic and nonpharmacologic treatment of NAS.  Other systematic reviews could be 
more expansive than this systematic review by including data on other pharmacologic and 
nonpharmacologic treatments not previously covered.  Further studies also need to address long-
term morbidity related to neonatal drug withdrawal and whether it is increased or decreased by 
pharmacologic treatment.  Future studies should also include whether continuing postnatal drug 
exposure creates risk of neurobehavioral damage and other morbidities. 
Conclusion 
Breastfeeding and rooming-in care are effective as stand-alone treatments for most NAS 
cases with mild to moderate symptoms.  Breastfeeding and rooming-in care should also be used 
in congruence with pharmacologic agents to treat moderate to severe symptoms of NAS unless 
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otherwise contraindicated.  Buprenorphine and methadone have been shown to be more effective 
at treating the symptoms of NAS than morphine while further research must be conducted to 
compare the effectiveness of buprenorphine to methadone.  Further research still needs to be 
conducted on the treatment of NAS to determine long-term effects of drug exposure and advance 
further practice. 
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Appendix 
Systematic Review Table of Evidence (TOE) 
APA Formatted 
Reference 
Purpose Statement and 
Research Question 
Setting, Sampling Methods, 
and Sample Size 
Design and 
Level of 
Evidence  
Findings / 
Conclusion 
Practice & Research 
Implications 
Limitations of 
Findings 
1: Abdel-Latif, M. E., 
Pinner, J., Clews, S., 
Cooke, F., Lui, K., & 
Oei, J. (2006). Effects 
of breast milk on the 
severity and outcome 
of neonatal abstinence 
syndrome among 
infants of drug-
dependent mothers. 
Pediatrics, 117(6), 
e1163–e1169. doi: 
10.1542/peds.2005-
1561 
Purpose Statement: To 
assess the effects of 
breast milk feeding on the 
severity of NAS in a 
population of infants of 
drug-dependent mothers 
who are at risk of NAS. 
Research Question: Is 
there a difference in the 
severity of NAS and the 
need for pharmacologic 
treatment of NAS in 
infants of drug-dependent 
mothers who consumed 
breast milk as opposed to 
formula? 
  
  
Setting: Royal Hospital 
for Women in Randwick, 
New South Wales, 
Australia. 
Sampling Method: 
Reviewed data from all of 
the infants of drug-
dependent mothers 
admitted to the Royal 
Hospital for Women 
between 1998 and 2004. 
Sample Size: A total of 
190 consecutive charts 
were reviewed for 
maternal and neonatal data 
with 105 formula-fed 
infants and 85 breast milk-
fed infants. 
Design: 
Retrospective 
cohort study 
Level of 
Evidence: 4  
Infants in the breast 
milk group had 
lower Finnegan 
scores, shorter 
LOS, delayed onset 
of withdrawal 
symptoms, and had 
a decreased need 
for pharmacologic 
treatment than 
infants in the 
formula group. 
Overall, breast milk 
intake significantly 
reduces the severity 
of NAS. 
Unless there are 
medical 
contraindications to 
breastfeeding, women 
of all infants at risk of 
NAS should be 
encouraged to 
breastfeed. 
The Finnegan 
scoring system 
was used to 
monitor 
withdrawal from 
all types of drugs 
although it is only 
validated to 
evaluate opiate 
withdrawal 
symptoms. There 
could be a threat to 
validity due to the 
higher number of 
premature infants 
in the formula 
group. There was 
no randomized 
group assignment. 
2: Abrahams, R. R., 
Kelly, S. A., Payne, 
S., Thiessen, P. N., 
Mackintosh, J., & 
Janssen, P. A. (2007). 
Rooming-in compared 
with standard care for 
newborns of mothers 
Purpose Statement: “To 
evaluate the effect of 
rooming in (rather than 
standard nursery care) on 
the incidence and severity 
of neonatal abstinence 
syndrome among opioid 
exposed newborns and on 
Setting: One group was 
from Vancouver General 
Hospital (VGH). The first 
comparison group was 
from B. C. Women’s 
Hospital (BCWH). The 
second comparison cohort 
was from Surrey Memorial 
Design: 
Retrospective 
Cohort Study 
Level of 
Evidence: 4   
Findings: 
Rooming in was 
found to be 
associated with a 
significant 
decrease in need 
for treatment for 
the newborn, 
Practice & Research 
Implications: 
Through the 
conclusion, we learned 
that treatment for NAS 
can’t be universally 
one particular 
treatment, due to the 
Limitations of 
Findings: Non- 
random allocation 
of subjects for 
study groups 
could be a 
limiting factor in 
the study design. I 
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using methadone or 
heroin. Canadian 
Family Physician, 
53(10), 1722–1730. 
http://cfp.ca/content/5
3/10/1722.long 
 
 
the proportion of mothers 
who retain custody of 
their babies at hospital 
discharge” (p. 1723). 
Research Question: Is 
there a decrease on the 
incidence and severity of 
NAS seeing among 
opioid exposed newborns 
and on the number of 
mothers who retain 
custody of their babies 
with the intervention of 
rooming, compared to a 
historical cohort and a 
concurrent cohort.    
Hospital (Surrey).  
Sampling Method: The 
study used women who 
during pregnancy used 
heroin or methadone 
between October 2001 and 
December 2002. The first 
comparison group included 
a historical cohort of every 
third woman who gave 
birth between January 
1999 and September 2001 
who used heroin or 
methadone or whose 
babies had NAS 
symptoms. The second 
comparison group included 
all women who were under 
the same category as 
above, between January 
1999 and December 2002. 
Both comparison groups, 
had babies separated from 
their mothers during the 
first week of life. 
Sample Size: A total of 96 
women were in the study, 
32 from VGH, 28 from 
BCWH, and a 36 from 
Surrey. .   
shorter hospital 
stay, and more 
likely to be 
discharged in their 
mother’s custody. 
Lifestyle related 
factors 
significantly 
impacted the 
outcomes of the 
study.  
When the study 
restricted their 
analysis to non- 
breastfeeding 
women, 
significantly fewer 
of the rooming in 
newborns required 
admission to a 
level 2 or 3 
nursery. It was 
stated that 
breastfeeding in 
this population 
might be delayed 
onset of NAS.  
impact of lifestyle 
related factors. The 
article states, “These 
results should 
encourage further 
study in the context of 
a randomized design 
with prognostic 
stratification on 
breastfeeding” (p. 
1730). Along with 
this, under care of 
nursing and medical 
staff, rooming in 
should be 
implemented more for 
a safe intervention for 
NAS.  
also noticed the 
sample sizes for 
the different 
groups were not 
the same, which 
could have 
possibly skewed 
the results. The 
study could not 
separate the 
effects of rooming 
in from those of 
breastfeeding, so 
they should 
replicate the study 
in a large sample 
of women not 
breastfeeding to 
explore outcomes 
independently 
linked with 
rooming in. .   
3: Abrahams, R. R., 
MacKay-Dunn, M. H., 
Nevmerjitskaia, V., 
MacRae, G. S., Payne, 
S. P., & Hodgson, Z. 
Purpose Statement: To 
determine if an 
interdisciplinary rooming-
in model of care affects 
clinical and psychosocial 
Setting: Fir Square unit of 
BC Women’s Hospital, 
Royal Columbian, Victoria 
General, Surrey Memorial, 
Matsqui-Sumas-
Design: 
Retrospective 
cohort study 
Level of 
Evidence: 4 
The rooming-in 
group had a 
significant decrease 
in admission and 
length of stay in the 
Rooming-in is valuable 
to the care of 
substance-exposed 
infants. Future areas of 
study include 
The study could 
not report how 
morphine 
administration 
changed neonatal 
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G. (2010). An 
evaluation of 
rooming-in among 
substance-exposed 
newborns in british 
columbia. Journal of 
Obstetrics and 
Gynaecology Canada, 
32(9), 866–871. doi: 
10.1016/S1701-
2163(16)34659-X 
outcomes in substance-
exposed newborns. 
Research Question: Is 
there a difference in 
clinical and psychosocial 
outcomes between 
substance-exposed 
newborns whose care 
follows a traditional 
standard care model as 
compared to an 
interdisciplinary rooming-
in model of care? 
Abbotsford General, 
Burnaby General, St. 
Paul’s, Richmond General, 
Lion’s Gate, Royal Inland, 
Kelowna General, 
Nanaimo Regional 
General, and Prince 
George Regional. 
Sampling Method: 
Reviewed data from all 
neonates of women who 
used substances during 
pregnancy that delivered in 
British Columbia between 
October 1, 2003 and 
December 31, 2006. 
Neonates and their mothers 
were put into two groups 
based on whether they 
gave birth at BC Women’s 
Hospital (where rooming-
in care was received) or 
elsewhere in British 
Columbia (where standard 
care was received). 
Sample Size: There were a 
total of 952 substance-
exposed neonates with 355 
in the rooming-in group 
and 597 in the standard 
care group. 
 NICU, an increased 
chance of receiving 
breast milk during 
their hospital stay, 
and an increased 
chance of being 
discharged home 
with their mothers. 
The standard care 
group was found to 
have a significantly 
shorter length of 
stay on average (11 
days compared to 
21 days in the 
rooming-in 
group).There was 
no significant 
difference between 
the two groups with 
respect to neonatal 
withdrawal 
symptoms. 
performing an 
economic evaluation 
for providing 
appropriate care to 
substance-using 
women and examining 
whether rooming-in 
influences morphine 
administration for 
neonatal withdrawal. 
outcomes because 
this variable 
wasn’t recorded. 
The presence or 
absence of 
neonatal 
withdrawal 
symptoms is 
considered 
unreliable because 
institutions vary 
on their reporting 
method. The study 
was unable to 
report which types 
of substances were 
used during 
pregnancy, which 
could affect the 
comparability of 
the two groups. 
4: Bagley, S. M., 
Wachman, E. M., 
Holland, E., & Brogly, 
S. B. (2014). Review 
Purpose Statement: 
“The objective of this 
review is to summarize 
available 
Setting: Articles that were 
used in this systematic 
search were found on 
PubMed and the Cochrane 
Design: 
Systematic 
Review 
Level of 
Findings: Four of 
the studies showed 
length of hospital 
stay three to 
Practice & Research 
Implications: 
This systematic review 
clearly showed through 
Limitations of 
Findings: Studies 
often didn’t 
differentiate 
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of the assessment and 
management of 
neonatal abstinence 
syndrome. Addiction 
Science & Clinical 
Practice, 9(19), 1-10.  
doi: 10.1186/1940-
0640-9-19 
evidence on the 
assessment and 
management of infants 
exposed to opioids in 
utero, including 
assessment 
tools used for NAS 
scoring, 
nonpharmacologic 
interventions, 
and pharmacologic 
management of NAS” (p. 
2). 
Research Question: 
What does published 
English-language 
literature have to say 
about assessment of NAS, 
as well as 
nonpharmacologic 
interventions and 
pharmacologic treatments 
for NAS?  
Database. The articles 
were published between 
1975 and November 15, 
2013. 
Sampling Method: 
Finding articles using 
specific keywords. For 
nonpharmacologic 
treatment, they included 
studies composed of 
cohort, case series, case 
control, and randomized 
controlled trials.  
Sample Size: 13 of the 
879 articles pertaining to 
nonpharmacologic 
interventions were 
included in this review.  
Evidence: 1  nineteen days 
shorter in breastfed 
infants. Four of the 
studies showed 30 
percent decrease in 
pharmacologic 
treatment for NAS. 
One study found 
breastfed infants 
showed signs of 
withdrawal 
significantly later 
than formula fed 
infants.  
In regards to 
rooming in, two 
studies showed 
overall decreased 
length of hospital 
stay and duration 
of therapy. 
These 
interventions 
increase bonding 
and help normalize 
the postpartum 
process for women 
with opioid history 
who may feel 
vulnerable and 
stigmatized.    
multiple articles that 
breastfeeding and 
rooming in help 
neonates with NAS. 
Due to these findings, 
it is crucial for 
hospitals to all start 
implementing these 
interventions by 
teaching their staff on 
how to implement 
them. The article stated 
that low breastfeeding 
rates in this population 
are likely due to 
feeding difficulties in 
these infants. This may 
open up a window for 
learning how to help 
these neonates with 
feeding difficulties. 
Further studies should 
also focus on how to 
increase rates of 
rooming in and 
breastfeeding.   
 
between 
expressed breast 
milk and 
breastfeeding, 
they did not 
compare 
exclusive 
breastfeeding 
versus 
combination 
feeding and 
neonates fed with 
formula only. 
Duration of 
breastfeeding was 
also not defined. 
Bias was also 
introduced due to 
the fact that 
criteria for 
permitting 
breastfeeding 
were not 
described in every 
study.  
5: Boucher, A. (2017). 
Nonopioid 
management of 
neonatal abstinence 
Purpose Statement: To 
examine the effectiveness 
of rooming-in care and 
acupuncture as 
Setting: PubMed, Ovid 
Medline, Embase, and 
CINAHL 
Sampling Method: The 
Design: 
Systematic 
Review 
Level of 
Several studies 
concluded that 
infants with NAS 
who receive 
Randomized controlled 
trials should be 
performed in the future 
in order to determine 
This study is 
nonrandomized 
and uncontrolled.  
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syndrome. Advances 
in Neonatal Care, 
17(2), 84–90. doi: 
10.1097/ANC.000000
0000000371 
nonpharmacologic 
treatments to decrease the 
amount of postpartum 
neonatal opioid exposure 
and length of hospital 
stay. 
Research Question: Is 
there a difference in 
amount of postpartum 
neonatal opioid exposure 
and length of hospital 
stay in neonates who 
receive rooming-in care 
and acupuncture? 
above databases were 
searched for primary 
sources on rooming-in care 
and acupuncture as 
treatments for NAS 
Sample Size: Eight 
research studies were 
chosen to be examined in 
this systematic review. 
Evidence: 1 
 
rooming-in care 
have a decreased 
likelihood of 
needing 
pharmacologic 
treatment; even 
when 
pharmacologic 
treatment is needed, 
length of hospital 
stay and opioid 
exposure is 
decreased. 
the necessary 
components of a 
rooming-in care model 
for NAS treatment. In 
the present, healthcare 
providers should be 
encouraged to offer 
rooming-in care to 
postpartum mothers 
with infants at risk for 
NAS. 
6: Brown, M. S., 
Hayes, M. J., & 
Thornton, L. M. 
(2015). Methadone 
versus morphine for 
treatment of neonatal 
abstinence syndrome: 
a prospective 
randomized clinical 
trial. Journal of 
Perinatology, 35(4), 
278–283. 
https://doi.org/10.1038
/jp.2014.194 
Purpose Statement: To 
compare the length of 
methadone and morphine 
treatment for Neonatal 
Abstinence Syndrome. 
Research Question: Is 
there a difference in the 
length of treatment for 
Neonatal Abstinence 
Syndrome between 
methadone and 
morphine? 
Setting: The Neonatal 
Intensive Care and 
Pediatric Inpatient units at 
Eastern Maine Medical 
Center. 
Sampling Method: 
Mothers in labor who were 
admitted between January 
2011 and October 2012 
were included in the study 
if they met the following 
criteria: “(i) prenatal 
exposure to prescribed 
methadone 
or buprenorphine, (ii) 
meeting our NAS 
treatment criteria, (iii) 
adjusted gestational age of 
> 350/7 weeks assessed 
from best menstrual, 
obstetrical and physical 
Design: 
Randomized 
Controlled 
Trial 
Level of 
Evidence: 2  
Findings: Length 
of treatment was 
significantly 
reduced for 
neonates treated 
with methadone 
(14 days) 
compared to 
neonates treated 
with morphine (21 
days). Neonates 
treated with 
methadone had a 
reduced need for a 
rescue drug 
compared to 
neonates treated 
with morphine; 
however, this 
finding wasn’t 
statistically 
Practice & Research 
Implications: A 
multicenter trial 
should be performed 
to enable the findings 
of the study to be 
generalized to the 
neonate population. 
Limitations of 
Findings: This 
study was a single 
site pilot and was 
unable to include 
as many neonates 
in the study as 
previously hoped. 
The small sample 
size means that 
findings cannot be 
generalized to the 
population. 
Findings could 
have been 
affected by the 
fact that maternal 
methadone doses 
at birth were 
lower in the 
neonates treated 
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exam criteria, and (iv) 
otherwise medically stable 
in the opinion of the 
attending neonatologist” 
(p. 279). Mothers and their 
infants who qualified were 
then randomly assigned to 
receive treatment with 
either morphine or 
methadone.  
Sample Size: 198 mother-
infants pairs were screened 
for inclusion in the study. 
Only 31 neonates met the 
inclusion criteria. 
significant. with methadone. 
Additionally, the 
sample population 
was mostly 
European 
American and 
therefore not 
ethnically diverse. 
7: Crook, K., & 
Brandon, D. (2017). 
Prenatal breastfeeding 
education: Impact on 
infants with neonatal 
abstinence syndrome. 
Lippincott Williams & 
Wilkins, 14(4), 299-
305. doi: 
10.1097/ANC.000000
0000000392 
 
 
Purpose Statement: “To 
increase breastfeeding 
rates and decrease 
hospital length of stay for 
infants with NAS through 
prenatal breastfeeding 
initiatives” (p. 299).   
Research Question: 
Would prenatal 
breastfeeding initiatives 
for mothers with infants 
suffering from NAS 
increase breastfeeding 
rates and decrease length? 
Setting: An outpatient OB 
clinic.   
Sampling Method: Infants 
in the study were divided 
into three groups; baseline 
status was births from 
February 2014 to August 
2014, baby friendly status 
(BFS) was births from 
September 2014 to January 
2015, then BFS plus 
breastfeeding education 
initiative were births from 
February 2015 to July 
2015. 
Sample Size: A total of 
200 infants were included 
in the study.  
Design: 
Controlled 
Trials without 
Randomizatio
n   
Level of 
Evidence: 3  
Findings: Average 
LOS for infants 
decreased from 
18.8 days in the 
baseline group, to 
13.1 days in the 
BFS group, to 10.4 
days in the BFS 
with additional 
breastfeeding 
education group. 
Additionally, 
infants who 
received more than 
50 percent human 
milk predicted to 
have a LOS that 
was 2.78 days 
shorter than infants 
who received all 
Practice & Research 
Implications: Due to 
results suggest that 
prenatal education 
may contribute to an 
increase in infants 
with NAS receiving 
breast milk, which 
results in a decrease in 
hospital length of stay, 
prenatal education 
needs to be more 
stressed about in the 
community.  
Limitations of 
Findings: The 
small sample 
cannot make it 
possible to infer 
direct impact of 
the intervention.  
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formula.  
8: Dryden, C., Young, 
D., Hepburn, M. and 
Mactier, H. (2009). 
Maternal methadone 
use in pregnancy: 
Factors associated 
with the development 
of neonatal abstinence 
syndrome and 
implications for health 
care resources. British 
Journal of Obstetrics 
& Gynaecology, 116, 
665–671. 
doi:10.1111/j.1471-
0528.2008.02073.x 
 
Purpose Statement: 
“To investigate factors 
associated with the 
development of NAS and 
to assess the implications 
for health care resources 
of infants born to drug 
misusing women” (p. 
665). 
Research Question: Is 
the implications provided 
by healthcare resources 
helping infants born to 
drug misusing women? 
Setting: An inner city 
maternity hospital, 
Princess Royal Maternity 
in Glasgow, United 
Kingdom. 
Sampling Method: The 
article presents data over a 
3 year period, from 
January 2004 to December 
2006 to a large cohort of 
drug misusing mothers.  
Sample Size: This article 
collected data for 437 
infants and 440 mothers.  
Design: 
Retrospective 
Cohort Study  
Level of 
Evidence: 4  
Findings: 
Breastfeeding for 
greater than or 
equal to 72 hours 
was associated 
with decreasing the 
odds of the neonate 
needing treatment 
for NAS by 50 
percent, which 
decreases their 
hospital stay. The 
article states 
breastfeeding 
soothes agitated 
infants, and the 
drugs taken by the 
mom are excreted 
in the milk, 
decreasing the 
effects of 
withdrawal. 
Postnatal stay was 
recommended for 
intensive parenting 
support. 
Practice & Research 
Implications: 
Learning preterm 
infants have a hard 
time suckling, and 
many drug misusing 
mothers choose not to 
breastfeed due to 
social prejudice, we 
need to increase 
programs to help these 
causes. The public 
needs to learn the 
importance of this 
intervention. We need 
appropriate support 
services in the 
community as well, 
because 50 percent 
neonates failed to 
attend outpatient 
appointments.     
Limitations of 
Findings: The 
article could have 
compared health 
care resources 
now provided for 
NAS, compared 
to those provided 
in the past, to 
have a 
comparison 
group.    
9: Hodgson, Z. G., & 
Abrahams, R. R. 
(2012). A Rooming-in 
Program to Mitigate 
the Need to Treat for 
Opiate Withdrawal in 
the Newborn. Journal 
of Obstetrics and 
Purpose Statement: 
“...to explore the effect of 
our rooming-in protocol 
on the need to treat 
withdrawal in the opiate- 
exposed newborn” (p. 
475). 
Research Question: 
Setting: Fir Square, a 
combined care unit within 
BC Women’s Hospital, 
mother-child dyads 
between 10/01/2003-  
12/31/2006. 
Sample Method: Mothers 
selected during a certain 
Design: 
Retrospective 
cohort study 
Level of 
Evidence: 4 
Findings: 
“...significant 
positive 
relationship 
between maternal 
methadone dose at 
delivery, ‘other 
opiate’ use, and 
Practice & Research 
Implications: 
Rooming-in is a safer 
and more beneficial 
alternative to the 
current standard 
practice of separating 
mother and opioid-
Limitations of 
Findings: 
Recommends 
looking into illicit 
drug use and 
methadone 
relationship over 
the course of the 
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Gynaecology Canada, 
34(5), 475–481. 
doi:10.1016/S1701-
2163(16)35245-8 
Does this rooming-in 
program help reduce the 
amount of maternal 
methadone required to 
treat opiate withdrawal in 
newborns? 
study period. 
Sample Size: 295 women 
between the age of 27.5 +/- 
6.2 years, 295 neonates. 
breastfeeding and 
the need to treat 
the neonate for 
withdrawal...mater
nal methadone 
dose at 
delivery...related to 
the duration of 
pharmacological 
treatment of the 
neonate” (p. 475). 
 
 
dependent infant. “The 
current study suggests 
a useful role for 
rooming-in in 
mitigating the 
relationship between 
maternal methadone 
dose and the need to 
treat the newborn for 
opiate withdrawal” (p. 
480).  
pregnancy to treat 
infant opioid 
withdrawal.  
10: Holmes, A., 
Atwood, E., Whalen, 
B., Beliveau, J., Jarvis, 
D., Matulis, J., 
Ralston, S. (2016). 
Rooming-in to treat 
neonatal abstinence 
syndrome: Improved 
family-centered care 
at lower cost. 
American Academy of 
Pediatrics, 137(6), e1-
e9. 
doi:10.1542/peds.2015
-2929 
 
Purpose Statement: 
“To determine how to 
improve the care of 
opioid-exposed newborns 
by involving families, 
standardizing assessment 
and treatment, and 
transitioning to rooming-
in for the full hospital 
stay” (p. e2).  
Research Question: Is 
there a difference in 
length of stay and 
hospital costs when a 
coordinated program for 
NAS is implemented, 
which includes 
standardized scoring, 
weaning of medications,, 
and a calm rooming in 
environment, compared to 
infants treated without 
Setting: Dartmouth-
Hitchcock, a Children’s 
Hospital, which provides 
inpatient, critical care, and 
pediatric specialty services 
to most of New Hampshire 
and a portion of Vermont. 
Sampling Method: The 
research included all birth 
hospitalizations between 
March 2012 and February 
2015, using patients with 
reported or laboratory 
confirmed maternal opioid 
use.  
Sample Size: Began with a 
pilot group of 10 opioid 
dependent women, then 
expanded it for all infants. 
163 newborns treated for 
NAS was used in the 
study. 69 newborns 
Design: 
Controlled 
Trials without 
Randomizatio
n 
Level of 
Evidence: 3 
Findings:  
For infants with 
NAS treated with 
the new 
implementations, 
LOS was reduced 
from 23 days to 12 
days, system costs 
decreased by more 
than half. Costs are 
decreased not only 
because the LOS is 
decreased, but due 
to the rooming  in 
model. Critical 
care beds no longer 
have to be used for 
this condition, 
which greatly 
decreases care 
costs.  
Practice & Research 
Implications: While 
achieving the 
outcomes they have 
hoped for, they also 
saw positive family 
engagement, increased 
family preparation and 
involvement, and 
trained clinical teams 
better on how to take 
care of these patient 
situations. These 
outcomes are major 
findings in the nursing 
realm, and shows that 
involving families, 
standardizing 
assessment and 
treatment, and 
rooming in for a full 
hospital stay should be 
Limitations of 
Findings:  
The same six 
pediatricians were 
attending to the 
patients. Mother’s 
in the hospital 
service area are 
maintained on 
buprenorphine 
more commonly 
than methadone, 
which is seen 
with a shorter 
length of 
treatment. 
Rooming-in 
program socially 
acceptable in 
Hampshire and 
Vermont because 
they do not 
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this program being 
implemented? 
received pharmacologic 
treatment, while 94 
newborns did not require 
pharmacological treatment 
and just focused on the 
interventions of the study. 
These included standardize 
scoring, rooming in, 
prenatal family education, 
and environmental 
management.   
seen in more hospitals 
in the future.     
impose 
mandatory foster 
care placement 
for opioid 
exposed 
newborns, unlike 
other states.   
 
11: Holmes, A. P., 
Schmidlin, H. N., & 
Kurzum, E. N. (2017). 
Breastfeeding 
considerations for 
mothers of infants 
with neonatal 
abstinence syndrome. 
Pharmacotherapy: 
The Journal of Human 
Pharmacology and 
Drug Therapy, 37(7), 
861–869. 
doi:10.1002/phar.1944 
Purpose Statement: To 
identify different benefits 
of breastfeeding infants 
with NAS to reduce 
withdrawal syndromes 
and determine the 
clinician's role in 
promoting, identifying, 
and counseling the 
mothers. 
Research Question: 
What role does the 
clinician have in 
advocating for mothers to 
breastfeed the infants 
born with NAS? 
Setting: Retrieved from 
databases. 
Sample Method: Multiple 
studies where some infants 
are breastfed and some are 
formula fed. Each article 
has its own requirements to 
determine which infants 
were formula fed and 
which were breastfed. 
Sample Size: Reviewed 
five studies with a focus on 
breastfeeding compared to 
formula feeding. 
 
Design: 
Systematic 
review 
Level of 
Evidence: 1 
Findings: 
Breastfeeding 
promotes weight 
gain, skin-to-skin 
contact, and the 
mother-infant 
bond. “…infants 
with NAS who 
were fed primarily 
breast milk 
compared with 
those fed formula 
had a later onset of 
NAS (10 vs 3 days, 
p<0.001), required 
pharmacologic 
treatment less often 
(52.9% vs 79%, 
p<0.001), and had 
a shorter length of 
stay (LOS) (15 vs 
19 days, p=0.049)” 
(p. 862). 
 
Practice & Research 
Implications: 
“Clinicians can play 
an important role in 
identifying, 
promoting, and 
counseling mothers of 
infants with NAS 
regarding 
breastfeeding” (p. 
868). Monitor for 
rebound NAS and 
mothers continuing to 
abuse substances. 
Limitations of 
Findings: 
Barriers to study 
include 
inconsistent and 
inaccurate data 
that causes 
healthcare 
providers to 
continue to 
discourage drug-
dependent 
mothers from 
breastfeeding. 
Social prejudice 
against the 
mothers is also 
another barrier to 
treatment.  
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12: Hudak, M. L., 
Tan, R. C., Drugs, T. 
C. O., & Newborn, T. 
C. on F. A. (2012). 
Neonatal drug 
withdrawal. 
Pediatrics, 129(2), 
e540–e560. 
doi:10.1542/peds.2011
-3212 
Purpose Statement: 
To explore “therapeutic 
options for treatment of 
withdrawal” and 
determine evidence-based 
management practices of 
the infant with NAS (p. 
1). 
Research Question: 
What are the current 
evidence-based practices 
for treatment and 
management of NAS? 
Setting: Multiple hospitals 
and healthcare clinics 
Sample Method: 
Reviewing scientific 
research on the subject of 
NAS  
Sample Size: N/A 
Design:  
Expert Opinion 
Level of 
Evidence: 7 
Findings: “Drug 
therapy is indicated 
to relieve moderate 
to severe signs of 
NAS and to 
prevent 
complications such 
as fever, weight 
loss, and seizures if 
an infant does not 
respond to a 
committed 
program of 
nonpharmacologic 
support” (p. e548). 
“When possible, 
and if not 
otherwise 
contraindicated, 
mothers who 
adhere to a 
supervised drug 
treatment program 
should be 
encouraged to 
breastfeed so long 
as the infant 
continues to gain 
weight. 
Breastfeeding or 
the feeding of 
human milk has 
been associated 
with less severe 
NAS that presents 
Practice & Research 
Implications: Each 
clinic should establish 
a threshold level for 
total opioid exposure, 
have weaning protocol 
for infants exposed to 
opioids, and monitor 
for S/S of withdrawal 
24 hours after 
discontinuing an 
opioid. Have protocol 
and screening in place 
at nurseries for S/S of 
NAS or risk of 
developing 
withdrawal.  
Limitations of 
Findings: 
“Studies have not 
addressed 
whether long-
term morbidity 
related to neonatal 
drug withdrawal 
is decreased by 
pharmacologic 
management of 
affected infants, 
or whether 
continued 
postnatal drug 
exposure 
augments the risk 
of 
neurobehavioral 
and other 
morbidities. It is 
possible that 
pharmacologic 
therapy of the 
infant may 
introduce or 
reinforce a 
maternal 
disposition to rely 
on drugs for the 
treatment of 
infant discomfort 
or annoying 
behavior” (p. 
e548). 
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later and less 
frequently requires 
pharmacologic 
intervention” (p. 
e548). 
 
13: Isemann, B., 
Meinzen-Derr, J., 
Akinbi, H. (2011). 
Maternal and neonatal 
factors impacting 
response to methadone 
therapy in infants 
treated for neonatal 
abstinence syndrome. 
Journal of 
Perinatology, 31, 25–
29. 
doi:10.1038/jp.2010.6
6 
 
Purpose Statement: To  
coordinate a managed 
care plan for opiate 
dependent women that 
reduces the public health 
burden posed by NAS, by 
outlining the risks of fetal 
drug exposure, 
emphasizes the benefits 
of providing mother 
breast milk to infants, and 
cautions against rapidly 
weaning infants from 
mother breast milk.    
Research Question: Is 
there a reduced public 
health burden posed by 
NAS when opiate 
dependent women are 
treated through a 
managed care plan?   
Setting: In the newborn 
intensive care unit at The 
University Hospital in 
Cincinnati, Ohio. 
Sampling Method: All 
newborns that received 
methadone therapy for 
NAS at The University 
Hospital between January 
2002 and December 2007. 
Sample Size: 128 infants, 
with a total of 1528 
methadone treatment days 
were included in the 
analyses. Of the 128 
infants, 56 of the term 
infants had breast milk 
available to them.     
Design: 
Retrospective 
Cohort Study 
Level of 
Evidence: 4   
Findings: Shorter 
median duration of 
methadone therapy 
in both preterm 
and term infants 
were found with 
infants feed breast 
milk. Breast milk 
feed infants had a 
shorter hospital 
stay, 3 to 51 days, 
compared to 
formula fed infants 
hospital stay 
ranging from 9 to 
43 days. Through 
the study they 
estimated that the 
intake of 
methadone from 
breast milk could 
be as high as 
0.05mg kg daily, 
which may help 
prevent or decrease 
the severity of 
NAS.  
Practice & Research 
Implications: 
Through the study, 
they taught the women 
not to abruptly stop 
infant’s ingestion of 
breast milk, for it 
could precipitate 
rebound withdrawal. I 
would like to see more 
future studies 
identifying infants at 
risk for rebound NAS.   
The article states 
providers should aim 
for a individualized 
approach to initial 
methadone dosing, 
which takes into 
consideration the 
gestational age and the 
availability of breast 
milk as a primary 
nutrition. Due to this 
finding, I think it is 
important for more 
physicians taught on 
proper methadone 
dosing.  
Limitations of 
Findings: The 
retrospective 
study had 
incomplete data 
collection from 
the medical 
records, and 
stated that infants 
rehospitalized for 
withdrawal 
symptoms may 
have been 
underestimated. 
Also, since the 
article was about 
benefits of 
breastfeeding to 
help with NAS, 
the article stated 
they may have 
possibly 
contributed to 
decreased length 
of hospital stay 
due to bias in 
initiating therapy.  
14: Jansson, L. M., Purpose Statement: To Setting: N/A Design: “More infants in the While it appears that The study’s results 
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Choo, R., Velez, M. 
L., Harrow, C., 
Schroeder, J. R., 
Shakleya, D. M., & 
Huestis, M. A. (2008). 
Methadone 
maintenance and 
breastfeeding in the 
neonatal period. 
Pediatrics, 121(1), 
106–114. 
doi:10.1542/peds.2007
-1182 
evaluate concentrations of 
methadone in breast milk 
as well as maternal and 
infant plasma among 
methadone-maintained 
breastfeeding women 
compared to formula-
feeding women. 
Research Question: Is 
there a difference in 
concentrations of 
methadone in breast milk 
as well as maternal and 
infant plasma among 
methadone-maintained 
breastfeeding women 
compared to formula-
feeding women? 
Sampling Method: 
Subjects enrolled in a 
substance abuse treatment 
program for pregnant and 
postpartum drug-
dependent women between 
January 2001 and 
September 2005. Subjects 
were included in the study 
if they met the following 
criteria: “Single daily dose 
of methadone, absence of 
significant fetal or 
maternal complications, 
singleton pregnancies, 
expressing a desire to 
breastfeed at routine 
obstetric care visits, 
abstinence from licit/illicit 
substance use after 32 
weeks gestation, and 
compliance with program 
standards” (p. 107). 
Sample Size: Eight 
women met the criteria and 
were called the 
breastfeeding group. These 
women were compared to 
eight control subjects who 
were called the formula-
feeding group. 
Controlled 
Trial without 
Randomizatio
n 
Level of 
Evidence: 3 
control (formula-
fed) group required 
pharmacologic 
treatment for NAS 
(4 infants, 
compared with 1 
breastfed infant), 
but this association 
was not statistically 
significant” (p. 
110). A substantial 
increase in 
methadone 
concentrations in 
breast milk was 
noted over time. 
“There was no 
significant 
correlation between 
maternal methadone 
doses and infant 
plasma methadone 
concentrations” 
(p.112). There was 
no association 
between neonatal 
methadone 
concentrations and 
breastfeeding or 
receiving 
pharmacologic 
treatment for NAS. 
the benefits of 
breastfeeding outweigh 
the effect a small 
concentration of 
methadone found in 
breast milk might have, 
more research should 
be performed to 
determine the long-
term effects of 
methadone on 
developing infants. 
Overall, the study 
recommends 
breastfeeding among 
pregnant women 
maintained on 
methadone. 
are based on very 
small group sizes. 
The results exhibit 
bias due to the 
need for 
reconstitution of 
several infant 
plasma specimens 
that dried out 
while in storage. 
This caused those 
concentration 
values to be 
overestimated. 
15: Kocherlakota, P. 
(2014). Neonatal 
abstinence syndrome. 
Purpose Statement: 
To explain NAS, its 
history, clinical 
Setting: Children’s 
Hospital at New York 
Medical College, Valhalla, 
Design: 
Systematic 
Review 
Findings: 
“Breastfeeding 
may decrease the 
Practice & Research 
Implications: Assess 
neurological and 
Limitations of 
Findings: 
Healthcare bias 
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Pediatrics, 134(2), 
e547–e561. 
doi:10.1542/peds.2013
-3524 
presentations, treatments, 
and discharge/follow-up. 
Research Question: 
What is Neonatal 
Abstinence Syndrome?  
New York. 
Sample Method: 
Complication of multiple 
journal articles. 
Sample Size: 187 journal 
articles. 
 Level of     
Evidence: 1 
incidence of NAS, 
the need for 
pharmacological 
treatment, and the 
length of the 
hospital stay” (p. 
e555). 
“Nonpharmacologi
cal therapy is the 
first option in all 
cases, and may 
suffice in cases of 
mild withdrawal. 
Nonpharmacologic
al therapy is easily 
acceptable, less 
expensive, and less 
controversial” (p. 
e553). 
motor function, 
psycho-behavioral 
behavior, growth and 
nutrition for 
abnormalities and 
setbacks.  
against mothers 
who breastfeed 
while on opioid 
agonist treatment. 
Mothers don’t 
continue 
breastfeeding 
after they leave 
the hospital. 
16: Kraft, W. K., 
Gibson, E., Dysart, K., 
Damle, V. S., 
LaRusso, J. L., 
Greenspan, J. S., … 
Ehrlich, M. E. (2008). 
Sublingual 
buprenorphine for 
treatment of neonatal 
abstinence syndrome: 
a randomized trial. 
Pediatrics, 122(3), 
e601–e607. 
https://doi.org/10.1542
/peds.2008-0571 
Purpose Statement: To 
determine the viability, 
safety, and effectiveness 
of treating neonates with 
Neonatal Abstinence 
Syndrome with 
sublingual buprenorphine 
compared to the standard 
care neonatal opium 
solution (NOS). 
Research Question: Is 
there a difference in 
viability, safety, and 
effectiveness of treating 
neonates with Neonatal 
Abstinence Syndrome 
Setting: Thomas Jefferson 
University Hospital in 
Philadelphia. 
Sampling Method: 
Mothers in labor who were 
admitted between April 
2005 and January 2008 
were included in the study 
if they met the following 
criteria: “>37 weeks’ 
gestation, exposure 
to opioids in utero, and 
demonstration of signs and 
symptoms of NAS that 
required treatment” (p. 
e602). Mothers and their 
Design: 
Randomized 
Controlled 
Trial 
Level of 
Evidence: 2  
Findings: The 
average length of 
treatment for 
neonates treated 
with 
buprenorphine was 
22 days compared 
to 32 days for 
neonates treated 
with NOS. The 
average length of 
hospital stay was 
27 days for 
neonates treated 
with 
buprenorphine 
Practice & Research 
Implications: 
Although the findings 
of this study suggest 
that buprenorphine is 
viable, safe, and 
effective treatment, a 
double-blind clinical 
trial with a larger 
sample size should be 
conducted in order for 
findings to be found 
statistically 
significant. 
Limitations of 
Findings: This 
study was a single 
site pilot study, 
which means that 
findings cannot be 
generalized to the 
neonate 
population as a 
whole. 
Additionally, bias 
couldn’t be 
completely 
eliminated during 
scoring of 
symptom severity. 
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with sublingual 
buprenorphine compared 
to neonatal opium 
solution (NOS)? 
infants who qualified were 
then randomly assigned to 
receive either sublingual 
buprenorphine or NOS. 
Sample Size: 26 neonates 
met the inclusion criteria. 
13 neonates were treated 
with buprenorphine and 13 
were treated with NOS. 
compared to 38 
days for neonates 
treated with NOS. 
Unfortunately, 
neither of these 
findings was 
statistically 
significant. 
17: Kraft, W. K., 
Adeniyi-Jones, S. C., 
Chervoneva, I., 
Greenspan, J. S., 
Abatemarco, D., 
Kaltenbach, K., 
Ehrlich, M. E. (2017). 
Buprenorphine for the 
treatment of the 
neonatal abstinence 
syndrome. New 
England Journal of 
Medicine 376(24), 
2341-2348. 
doi:10.1056/NEJMoa1
614835 
Purpose Statement: “In 
the single-site, 
randomized, double-
blind, double-dummy 
Blinded 
Buprenorphine or 
Neonatal Morphine 
Solution 
(BBORN) trial, we 
compared sublingual 
buprenorphine with oral 
morphine with respect 
to the duration of 
treatment in infants with 
the neonatal abstinence 
syndrome” (p. 2342). 
Research Question: 
Which pharmacologic 
treatment decreases the 
duration of treatment in 
infants with NAS, 
buprenorphine or 
morphine? 
Setting: Thomas Jefferson 
University Hospital in 
Philadelphia 
Sampling Method: 
Mothers in this study were 
enrolled in an outpatient 
methadone treatment 
program from October 31, 
2011 and May 29, 2016. 
30 infants were randomly 
assigned to receive 
buprenorphine, while 28 
were randomly assigned to 
receive morphine. 
Sample Size: 63 infants 
Design: 
Randomized 
Controlled 
Trial 
Level of 
Evidence: 2 
Findings: 
Buprenorphine is 
useful for 
treatment of 
neonatal 
abstinence 
syndrome due to 
its large 
therapeutic index 
for respiratory 
depression, along 
with having a long 
half-life. Primary 
outcomes included 
a decrease of 
duration of 
treatment with 
buprenorphine, 
with the mean 
number of days 13 
days decrease 
compared to those 
treated with 
morphine. A 
decrease LOS of a 
mean of 12 days 
Practice & Research 
Implications: This 
studies results shares 
the benefits of 
buprenorphine over 
morphine drug, 
showing the 
buprenorphine is 
beneficial to the 
treatment of NAS. 
With these results, 
buprenorphine should 
be used more often in 
these cases, and more 
research should be 
involved in this topic.  
Limitations of 
Findings: Some 
limitations of this 
study include the 
small sample size 
and the single 
center design. The 
study also 
excluded preterm 
infants and those 
with 
benzodiazepine 
exposure in utero, 
causing the results 
to be invalid to 
this population.  
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was found with 
buprenorphine.  
18: Liu, A., Juarez, J., 
Nair, A., & Nanan, R. 
(2015). Feeding 
modalities and the 
onset of the neonatal 
abstinence syndrome. 
Frontiers in 
Pediatrics, 3(14), 1-4. 
doi:10.3389/fped.2015
.00014 
 Purpose Statement: 
“...to compare the impact 
of different feeding 
modalities on the onset of 
NAS” (p. 1). 
Research Question: 
What is the mechanism 
behind the beneficial 
effect of breast milk? 
Setting: Two birthing 
units in Western Sydney 
from 2000 to 2006. 
Sample Method: 
Researchers looked at the 
medical records of 194 
cases and organized the 
infants within the first 2 
days of life. One group 
was mainly breastfed while 
the other was mainly 
formula fed. 
Sample Size: “…194 
methadone-maintained 
mother/infant dyads” (p. 
1). 
Design: 
Retrospective 
Cohort Study 
 Level of 
Evidence: 4 
 
Findings: 
“After adjusting 
for confounders, 
there was no 
significant effect of 
the modality of 
feeding on the 
rates of NAS 
requiring treatment 
(p = 0.11). 
Breastfeeding 
significantly 
delayed the onset 
of NAS (p = 0.04). 
The act of 
breastfeeding in 
the first 2 days of 
life had no effect 
on whether an 
infant required 
treatment for NAS 
when compared to 
those fed EBM or 
formula” (p. 1). 
Practice & Research 
Implications: 
Breastfed infants 
reacted to NAS the 
same as those who 
were formula fed. 
They encourage 
breastfeeding unless 
contraindicated in the 
mother. Breastfeeding 
isn’t negative 
concerning NAS 
treatment and has 
other positive benefits. 
 
Limitations of 
Findings: 
The small sample 
size of the sample 
groups made it 
difficult to prove 
the advantages of 
breastfeeding for 
infants with NAS. 
19: McKnight, S., 
Coo, H., Davies, G., 
Holmes, B., Newman, 
A., Newton, L., & 
Dow, K. (2015). 
Rooming-in for 
infants at risk of 
neonatal abstinence 
syndrome. American 
Purpose Statement: To 
determine the impact of 
rooming-in care for 
infants at risk of NAS on 
the necessity for 
pharmacologic treatment 
and length of hospital 
stay. 
Research Question: Is 
Setting: Kingston General 
Hospital in Ontario, 
Canada 
Sampling Method: The 
study population was all 
infants considered at risk 
of developing NAS. The 
population was split into 
two groups. The first group 
Design: 
Retrospective 
cohort study 
Level of 
Evidence: 4 
The need for 
pharmacologic 
treatment has a 
strong association 
with the length of 
hospital stay. 
Rooming-in was 
found to decrease 
the need for 
Future studies should 
examine the cost 
differences between 
rooming-in and 
admission to the NICU. 
More research should 
be done to test the 
relationship between 
breastfeeding and 
The study was 
nonrandomized 
and uncontrolled. 
The study’s small 
population 
numbers could 
have made it 
difficult to 
statistically detect 
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Journal of 
Perinatology, 33(5), 
495-501. 
doi:10.1055/s-0035-
1566295 
there a difference in the 
need for pharmacologic 
treatment and length of 
hospitalization for infants 
at risk of neonatal 
abstinence syndrome 
(NAS) who take part in a 
rooming-in program 
compared to those who 
receive standard care? 
of infants was born 
between May 1, 2012 and 
May 31, 2013 as these 
infants were admitted to 
the NICU. Infants born 
between June and August 
of 2013 were excluded. 
The second group of 
infants was born between 
September 1, 2013 and 
September 30, 2014 as 
these infants roomed-in 
with their mothers. 
Sample Size: There were a 
total of 44 infants with 24 
in the NICU group and 20 
in the rooming-in group. 
pharmacologic 
treatment, decrease 
length of hospital 
stay, and is 
independent of 
breastfeeding. 
rooming-in. Futures 
research should 
evaluate the possible 
barriers to employing 
rooming-in for 
pregnant substance 
users and their 
neonates. 
differences 
between the two 
groups that could 
have affected the 
study’s results. 
The study did not 
compare the types 
of drugs used by 
the mothers in the 
two groups. 
20: Newman, A., 
Davies, G. A., Dow, 
K., Holmes, B., 
Macdonald, J., 
McKnight, S., & 
Newton, L. (2015). 
Rooming-in care for 
infants of opioid-
dependent mothers: 
Implementation and 
evaluation at a tertiary 
care hospital. 
Canadian Family 
Physician, 61(12), 
e555–e561. Retrieved 
from 
http://web.a.ebscohost.
com.ezproxy.uakron.e
Purpose Statement: “To 
implement a rooming-in 
program to support close 
uninterrupted contact 
between opioid-dependent 
women and their infants in 
order to decrease the 
severity of NAS scores, 
lessen the need for 
pharmacotherapy, and 
shorten hospital stays” (p. 
e555). 
Research Question: Is 
there a difference in 
severity of NAS scores, 
the need for 
pharmacotherapy, or 
length of hospital stay 
Setting: Kingston General 
Hospital located in 
Ontario. A tertiary care 
referral centre with a level 
3 NICU.   
Sampling Method: All 
known opioid dependent 
mothers attending the 
multidisciplinary antenatal 
clinics by September 30th, 
2014. Exclusion criteria if 
had planned apprehension 
by child protection 
services or existence of 
another neonatal condition 
that would require 
admission to the NICU.   
Sample Size: 21 women 
Design: 
Controlled 
Trials without 
Randomizatio
n 
Level of 
Evidence: 3 
Findings: The 
neonates in the 
rooming in cohort 
had significantly 
lower oral 
morphine therapy 
(14.3%) compared 
to those admitted 
directly to the 
NICU (83.3%). 
The LOS for those 
rooming in was 7.9 
days, compared to 
24.8 days seen in 
those directly 
admitted to the 
NICU.  
Practice & Research 
Implications: Due to 
the significant 
findings in this 
research article, it is 
important for more 
hospitals to implement 
neonates rooming in 
rather than admitting 
them to the NICU.   
Limitations of 
Findings: There 
might be a 
possible source of 
bias regarding the 
NAS scoring tool, 
for to quantify 
withdrawal 
severity, 
subjective 
judgment is used 
to some degree. 
Future research 
also has to be 
done to look at 
neonatal and 
childhood 
outcomes in the 
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du 
 
with opioid dependent 
mothers and their neonates 
cared for with the new 
rooming in program, 
compared to those not 
rooming in?   
were admitted to a private 
room in the pediatrics unit 
with their full term infants. 
24 women whose babies 
were directly admitted to 
the NICU for direct 
observation. 
long run.  
21: O’Connor, A. B., 
Collett, A., Alto, W. 
A., & O’Brien, L. M. 
(2013). Breastfeeding 
rates and the 
relationship between 
breastfeeding and 
neonatal abstinence 
syndrome in women 
maintained on 
buprenorphine during 
pregnancy. Journal of 
Midwifery & Women’s 
Health, 58(4), 383–
388. 
doi:10.1111/jmwh.120
09   
 
Purpose Statement: To 
examine breastfeeding 
rates among opioid-
dependent pregnant 
women on buprenorphine 
maintenance treatment 
and to determine the 
effects of breastfeeding 
on length, intensity, and 
frequency of 
pharmacologic treatment 
for neonates with NAS. 
Research Question: Is 
there a difference in 
length, intensity, and 
frequency of 
pharmacologic treatment 
for neonates with NAS 
who receive breast milk 
compared to non-
breastfed neonates? 
Setting: “An integrated 
medical and behavioral 
health program for opioid-
dependent women…” (p. 
384). 
Sampling Method: The 
charts of all opioid-
dependent pregnant 
women on buprenorphine 
maintenance treatment 
who were in the integrated 
program from December 
2007 to August 2012 were 
reviewed. 
Sample Size: 85 mother-
infant pairs were examined 
in this study. 
Design: 
Retrospective 
cohort study 
Level of 
Evidence: 4 
 
“Although not 
statistically 
significant, 
preliminary results 
suggest that 
breastfeeding may 
attenuate NAS” (p. 
385). The average 
NAS score and 
likelihood of 
pharmacologic 
treatment were 
lower in breastfed 
neonates. NAS 
symptoms resolved 
approximately 2 
hours earlier in 
breastfed neonates 
than in non-
breastfed neonates. 
Although initial 
findings are positive, 
more research should 
be done with larger 
sample sizes to 
determine if 
breastfeeding causes a 
statistically significant 
difference in NAS 
severity and need for 
pharmacologic 
treatment. 
This study could 
not measure the 
effects of 
breastfeeding on 
length of hospital 
stay because other 
variables (such as 
pregnancy 
complications 
other than NAS) 
were present in the 
study’s sample. 
Because this study 
is nonrandomized 
and uncontrolled, 
it cannot be used 
to determine cause 
and effect. There 
was information 
missing regarding 
why the women in 
this study chose to 
begin and/or stop 
breastfeeding. 
Additionally, it is 
hard to 
differentiate the 
positive effects of 
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breastfeeding from 
other 
nonpharmacologic 
treatments, such as 
skin-to-skin 
contact that occurs 
during 
breastfeeding. The 
small sample size, 
especially 
regarding the 
number of 
neonates in the 
non-breastfed 
group, diminished 
the study’s ability 
to show statistical 
significance. 
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22: Ordean, A., 
Kahan, M., Graves, L., 
Abrahams, R., & Kim, 
T. (2015). Obstetrical 
and neonatal outcomes 
of methadone-
maintained pregnant 
women: A canadian 
multisite cohort study. 
Journal of Obstetrics 
and Gynaecology 
Canada, 37(3), 252–
257. 
doi:10.1016/S1701-
2163(15)30311-X 
Purpose Statement: To 
compare obstetrical and 
neonatal outcomes, 
including NAS, among 
methadone-maintained 
pregnant women across 
three Canadian 
metropolitan cities. 
Research Question: Is 
there a difference in 
obstetrical and neonatal 
outcomes, including 
NAS, among methadone-
maintained pregnant 
women across three 
Canadian metropolitan 
cities? 
Setting: The Sheway 
Clinic in Vancouver 
(which uses rooming-in 
care for infants with NAS), 
the Toronto Centre for 
Substance Use in 
Pregnancy, and the Herzl 
Family Practice Centre in 
Montreal (both of which 
admit infants with NAS to 
the NICU). 
Sampling Method: 
Reviewed the medical 
records of pregnant women 
with a history of opioid use 
that were eligible for or 
already receiving 
methadone-maintenance 
treatment (MMT) at 
integrated care programs in 
three Canadian cities from 
1997 to 2009. 
Sample Size: There were a 
total of 94 women in the 
study with 36 from 
Toronto, 36 from 
Vancouver, and 22 from 
Montreal. 
Design: 
Retrospective 
cohort study 
Level of 
Evidence: 4 
In the Vancouver 
site where rooming-
in care was used, 
there was a reduced 
rate of NICU 
admission, an 
increased length of 
hospital stay, and a 
shorter duration of 
NAS treatment. 
These findings are 
all consistent with 
the hypothesis that 
rooming-in 
decreases the need 
for treatment of 
newborns with 
NAS. 
Policies should 
promote maternal-
newborn contact, 
rooming-in care, and 
breastfeeding as 
methods to decrease 
NAS symptoms and 
the need for 
pharmacologic 
treatment. 
This study is 
nonrandomized 
and uncontrolled. 
There are 
inconsistencies 
and omissions in 
the data due to 
frequent 
documentation 
issues in patient 
charts. 
Additionally, the 
results of this 
study may not be 
universally 
applicable to 
methadone-
maintained 
pregnant women 
who have not 
received prenatal 
care. 
23: Pritham, U. A. 
(2013). Breastfeeding 
promotion for 
management of 
neonatal abstinence 
syndrome. Journal of 
Obstetric, Gynecologic 
Purpose Statement:  
“...to educate perinatal 
clinicians and substance 
abuse treatment 
specialists about NAS 
and the interplay of 
breastfeeding, skin-to-
Setting: PubMed, 
CINAHL, and Medline 
Sample Method: In the 
databases mentioned above, 
the keywords used were: 
“…opioid dependency in 
pregnancy, neonatal 
Design: 
Systematic 
Review 
Level of 
Evidence: 1 
Findings: 
Breastfeeding is 
shown to decrease 
need of treatment, 
LOS, severity, and 
duration of NAS. 
It is also shown to 
Practice & Research 
Implications: This 
study encourages 
healthcare workers to 
reassure and educate 
the mothers of opioid-
dependent infants about 
Limitations of 
Findings: 
“Further research 
is needed to 
determine 
differences in 
NAS between 
THE EFFECT OF BREASTFEEDING AND ROOMING-IN CARE ON NEONATAL            54                
& Neonatal Nursing, 
42(5), 517–526. 
doi:10.1111/1552-
6909.12242 
skin contact, and 
swaddling on NAS 
symptom management” 
(p. 517). 
Research Question: 
Should breastfeeding be 
recommended as a long-
term health treatment for 
high risk mothers and 
their newborn infants 
with NAS?  
 
abstinence syndrome, 
methadone, buprenorphine, 
neonatal length of stay, 
breastfeeding, methadone in 
breast milk, buprenorphine 
in breast milk, swaddling, 
and rooming-in” (p. 517). 
Sample Size: Articles 
published between January 
1990 and April 2013. 
promote bonding 
and infant 
attachment 
between the 
mother and child. 
the benefits of 
breastfeeding, both for 
the mother and infant. 
neonates who 
were breastfed 
and those who 
were fed pumped 
breast milk or 
donor milk. The 
safety of 
breastfeeding 
while on 
psychotropic 
medications with 
opioid 
replacement 
therapy also needs 
further 
exploration” (p. 
524). 
24: Raffaeli, G., 
Cavallaro, G., 
Allegaert, K., 
Wildschut, E. D., 
Fumagalli, M., Agosti, 
M., Tibboel, D., 
Mosca, F. (2017). 
Neonatal abstinence 
syndrome: Update on 
diagnostic and 
therapeutic strategies. 
Pharmacotherapy 
Publications 37(7), 
814-823. 
doi:10.1002/phar.1954 
 
Purpose Statement: 
“The aim of this review 
is to examine recent 
and relevant scientific 
literature on NAS, to 
increase awareness of the 
severe potential impact 
of in utero drug exposure 
on the developing 
child, and to highlight 
preventive strategies, 
early diagnosis, 
educational programs, 
evidence based 
standardized 
management, and 
research 
agendas as priority 
Setting: Medical journals. 
Sampling Method: 
Reviewing recent and 
relevant scientific literature 
on NAS. 
Sample Size: N/A 
Design: 
Expert 
Opinion 
Level of 
Evidence: 7  
Findings: 
Morphine is often 
the first line agent 
to treat NAS with 
methadone being 
another alternative, 
but its safety 
profile is not 
totally known. 50-
80% of opiate 
exposed neonates 
require 
pharmacologic 
management.  
Compared with 
methadone, 
buprenorphine-
exposed neonates 
Practice & Research 
Implications: More 
tailored therapy 
regarding 
pharmacologic 
management should be 
done to better 
understand the risks 
associated with them. 
Community awareness 
of the impact of NAS 
on health care will 
maybe generate 
supportive policies to 
expand on research 
related to this topic.  
Implementation of 
standard weaning 
Limitations of 
Findings: 
Limitations of 
this study involve 
no specifically 
stating how many 
articles were 
reviewed, where 
they were found, 
and the time 
period these 
articles were 
published.  
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issues” (p. 815). 
Research Question: 
What does recent and 
relevant scientific 
literature have to say 
regarding NAS, and 
evidence based 
standardized 
management?  
have a milder NAS 
course. 
protocols is also 
important to research 
more on, for it has a 
positive impact on 
length of 
pharmacologic 
therapy.  
25: Saiki, T., Lee, S., 
Hannam, S., & 
Greenough, A. (2010). 
Neonatal abstinence 
syndrome—postnatal 
ward versus neonatal 
unit management. 
European Journal of 
Pediatrics, 169(1), 95. 
doi:10.1007/s00431-
009-0994-0 
Purpose Statement: To 
determine if caring for 
infants with NAS on the 
postpartum unit with 
their mothers will reduce 
treatment duration and 
length of hospital stay 
when compared to infants 
admitted to the NICU or 
neonatal unit. 
Research Question: Is 
there a difference in 
treatment duration and 
length of hospital stay in 
infants with NAS when 
they are cared for on the 
postpartum unit 
compared to in the NICU 
or neonatal unit? 
Setting: King’s College 
Hospital (KCH) in 
Denmark Hill, London, 
UK 
Sampling Method: Two 
groups of infants with NAS 
were examined. The first 
group was comprised of all 
infants with NAS cared for 
between 2002 and 2005 
who were admitted to the 
neonatal unit. The second 
group was comprised of all 
infants with NAS cared for 
between 2006 and 2007 
who remained on the 
postpartum unit with their 
mother. 
Sample Size: There were 
42 infants in the neonatal 
unit group and 18 infants 
in the postpartum unit 
group. 
Design: 
Retrospective 
cohort study 
Level of 
Evidence: 4 
Infants who were 
cared for on the 
postpartum unit 
with their mother 
required less 
treatment, a 
decreased length of 
treatment, and a 
decreased length of 
hospital stay. 
Further studies, 
particularly 
randomized trials, 
should be performed to 
examine postpartum 
unit management of 
infants with NAS. 
The largest 
limitation to this 
study was that it 
was not a 
randomized trial. 
26: Welle-Strand, G. 
K., Skurtveit, S., 
Jansson, L. M., 
Purpose Statement: “To 
examine the rate and 
duration of breastfeeding 
Setting: Regional 
treatment centres for OMT 
in Norway, 18 different 
Design: 
Retrospective 
Cohort Study 
Findings: 77 
percent of the 
women in OMT 
Practice & Research 
Implications: Since 
breastfeeding benefits 
Limitations of 
Findings: Only 
one part of the 
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Bakstad, B., Bjarkø, 
L., & Ravndal, E. 
(2013). Breastfeeding 
reduces the need for 
withdrawal treatment 
in opioid exposed 
infants. Acta 
Paediatrica, 102(11), 
1060-1066. 
doi:10.1111/APA.123
78 
 
 
in a cohort of women in 
opioid maintenance 
treatment (OMT) in 
Norwary, as well as the 
effect of breastfeeding on 
the incidence and 
duration of NAS” (p. 
1060).  
Research Question: Is 
there a difference in the 
duration or incidence of 
NAS as a result of 
breastfeeding in a cohort 
of women in OMT?  
hospitals were used.   
Sampling Method: “A 
national cohort of women 
treated with either 
methadone or 
buprenorphine during 
pregnancy, and their 
neonates born between 
1999 and 2009” (p. 1060). 
A standard questionnaire 
was passed out and 
medical information was 
collected to confirm self- 
reported data.  
Sample Size: A total of 
124 women and children 
were included in this study.  
Level of 
Evidence: 4   
breastfed. 
Breastfed neonates 
who prenatally 
were exposed to 
methadone 
required less 
pharmacotherapy 
for NAS. All 
breastfed neonates 
needed less 
pharmacological 
treatment for NAS 
compared to those 
who were not 
breastfed. 
both the mother and 
child, we need to 
increase the rates 
among women in 
OMT. We need to 
increase support for 
these women. It may 
already be harder for 
them due to lactation 
difficulty found in 
OMT women and Nas 
associated behaviours 
make breastfeeding 
more difficult.  
study consisted of 
a prospective 
design, and the 
retrospectively 
designed study 
maybe have less 
accurate data due 
to relying on 
recall. Also, the 
children were 
born in 18 
different hospitals 
with different 
assessment skills 
of NAS at each. 
Lastly, the 
questionnaire did 
not cover 
breastfeeding that 
in depth, so we 
don’t know how 
long the women 
exclusively 
breastfed for.  
 
